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ABSTRACT
Stability of protein-based pharmaceuticals is compromised by a
variety of physical and chemical degradation pathways which
substantially lower formulation efficacy. Biological activity can be
lost as a result of chemical decomposition (cleavage of peptide bonds
and such destructions of amino acid residues as oxidation,
deamidation and B-elimination), as well as physical (conformational)
instability--loss of native structure caused by the disruption of non-
covalent interactions (e.g. aggregation and adsorption).
The instability and aggregation of insulin solutions present
serious problems for thE traditional injection therapy of diabetes
mellitus, and for the design of alternative methods of drug delivery
and administration: aggregation f insulin preparations causes loss
of potency and the inert aggregates obstruct tubing and catheters.
The mechanism and kinetics of insulin aggregation have not been
fully elucidated; yet, a better understanding of the degradation
process is necessary for the design of rational stabilization strategies
which specifically target the destabilizing pathways.
The goals of this investigation were to gain a fundamental
understanding of insulin aggregation and to improve insulin stability
in aqueous environments. Aggregation rates were studied by
varying some of the basic destabilizing parameters: agitation rates,
interfacial interactions, insulin concentration, Zn2 + content, solvent,
and temperature. The reaction time course was followed by
monitoring the concentration of non-aggregated species using UV
absorbance at 280 nm. Quasielastic light scattering analysis was
used to determine the particle size distribution and to detect the
formation of high molecular weight intermediates.
The combination of experimental observations and
mathematical modeling led to the formulation of a reaction scheme
describing insulin aggregation in agitated aqueous solutions
containing solid hydrophobic surfaces. Initial destabilization was
attributed to monomer denaturation at hydrophobic surfaces,
followed by the formation of stable intermediate species which
facilitated subsequent aggregation. The proposed mechanism
identified possible pathways of destabilization, predicted the
qualitative shape of kinetic profiles, and explained increased stability
at higher insulin concentrations.
Stabilization strategies (based on the developed model for
insulin aggregation) were proposed and verified. The mechanism of
stabilization in the presence of an air-water interface was elucidated.
Sugar-based nonionic surfactants (which excluded insulin from the
hydrophobic interface) increased solution stability from 6 hours to
more than 6 weeks for bovine Zn-insulin; Na-human insulin's
stability was similarly enhanced from 2 hours to 6 weeks.
The model's ability to predict trends in insulin aggregation
behavior suggested that it was an adequate representation of the
aggregation processes, while the success of the stabilizing strategy
indicated that the model identified one of the most important
pathways of destabilization. These results illustrate how a
fundamental understanding of physical degradation can be used to
improve the stability of protein formulations.
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CHAPTER 1.
INTRODUCTION
1.1 Stability Issues for Protein-based Pharmaceuticals.
Recent advances in biotechnology and genetic engineering have
made possible the production of many important proteins. The
successful implementation of these products, however, requires
careful handling and processing conditions which do not interfere
with the stability and biological activity of the proteins. Protein-
based pharmaceuticals are subject to many chemical and physical
degradation pathways: chemical decomposition leads to loss of native
structure through cleavage of peptide bonds and the destruction of
amino-acid residues, while physical instability refers to
conformational changes resulting from disruption of non-covalent
interactions (Manning et al., 1989). In most cases, only the native
conformation is biologically active, so it is important to preserve both
the chemical integrity and the three-dimensional structure or folding
of the protein.
While the mechanisms of many chemical degradation processes
have been identified (e.g. proteolysis, oxidation, deamidation and B-
elimination) and ways to improve chemical stability have been
proposed (Manning et al., 1989; Banga and Chien, 1988), physical
instability (particularly protein aggregation) continues to present
serious problems during production, storage and administration of
protein-based drugs. Protein denaturation or unfolding is usually
accompanied by the exposure of hydrophobic groups which are
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normally buried in the interior of the molecule; the resulting
conformations are unstable and seek to minimize their surface
energy by interacting with other unfolded molecules in order to
shield the hydrophobic moieties from the aqueous environment (Joly,
1965). In effect, aggregation locks in the denatured structure,
making it nearly impossible to recover the protein's biological
activity.
A fundamental understanding of the degradation mechanisms
is necessary to protect the protein's biological functions: when the
causes and pathways of instability are identified, rational
stabilization strategies can be designed. While every protein will
present the investigators with problems and concerns unique to its
structure and function, some trends in physical stability will be
common to many systems, so the understanding gained with a model
protein (or at least the experimental approach used to study the
mechanism of degradation) can contribute to improving formulation
stability of other biomolecules.
1.2 Insulin: a Model Protein for Studying Aggregation.
Insulin regulates the transport of glucose from the bloodstream
into cells where glucose is metabolized (Orci et al., 1988). The
inability to produce adequate amounts of this hormone and the
associated glucose intolerance and accumulation in the blood are the
characteristic symptoms of diabetes mellitus (Orci et al., 1988). Since
its discovery in the early 1920s (Banting and Best, 1922), insulin has
become one of the most important and commonly used therapeutic
proteins.
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Insulin is a globular hydrophobic protein made up of two
polypeptide chains (A and B) held together by 3 disulfide bonds
(Figure 1.1). The hormone contains 51 amino acid residues and
weighs -5800 daltons (Blundell et al., 1972). The insulin precursor,
proinsulin, is synthesized in the pancreatic beta cells, and
subsequently converted to insulin by the enzymatic cleavage of the C
peptide (Derewenda et al., 1989). Because of its medical importance,
insulin is one of the most thoroughly studied molecules; it is the first
protein whose chemical sequence was determined (Ryle et al., 1955)
and it is the first to be commercially produced by recombinant DNA
techniques (Johnson, 1983). Extensive studies of its 3-dimensional
structure by X-ray crystallography have been undertaken (Blundell
et al., 1972), and the amino-acid sequence of the insulin receptor has
been recently determined (Derewenda et al., 1989). Insulin's small
size, which makes it a particularly attractive protein for sequencing
studies, puts it at the detection limits of many analytical methods
used in solution studies. The low solubility of Zn-insulin at
physiological pH and its tendency to adsorb to many different
materials, further increase the difficulties involved in experimental
work (Helmerhorst and Stokes, 1986; Jeffrey, 1986; Cuatrecasas and
Hollenberg, 1975). Despite these problems, insulin's conformation in
solution has recently been investigated using advanced NMR (Weiss
et al., 1989; Ramesh and Bradbury, 1987), circular dichroism (Pocker
and Biswas, 1980; Sato et al., 1983) and SEM techniques (Salemnik et
al., 1989).
The biologically active form of the hormone (which circulates in
vivo and binds to the receptor) is monomeric, but insulin readily
19
Figure 1.1: A schematic representation of the insulin molecule.
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associates into dimers, and in the presence of zinc, three dimers
assemble into a hexamer (Figure 1.2). The hydrophobic region of the
insulin monomer involved in dimer and hexamer formation is the
same portion of the molecule which binds to the receptor, and is
responsible for the regulatory function of the hormone (Helmerhorst
and Stokes, 1986). The monomer's self-association into dimers and
hexamers leads to the burial of hydrophobic moieties, resulting in
stable structures with largely polar surfaces. The hexamers
crystalize readily; this conformation, which is used for storage in the
pancreatic beta cells, has a very low solubility (Derewenda et al.,
1989; Brange, 1987). Despite the wealth of information available in
the literature about insulin's structure and function, the mechanism
of physical degradation has not been fully elucidated.
1.3 Diabetes Mellitus: Current Therapies and Problems
Diabetes mellitus is an auto-immune disease which affects
millions of people in the U.S. and world-wide; in this country,
diabetes is the leading cause of blindness and one of the leading
causes of death. Left untreated, the disease is fatal: the patients
cannot use carbohydrates to fulfill their energy requirements, and
must rely instead on fat and muscle metabolism; this leads to
elevated blood levels of organic acids which cause ketoacidosis and
diabetic comma (Brown, 1983).
The two most commonly encountered disorders are insulin
dependent (Type I) and non-insulin dependent (Type II) diabetes
(Pyke, 1989). The causes behind the onset of diabetes remain
unknown, although there is convincing evidence that the destruction
21
Figure 1.2: The assembly of insulin hexamer from monomers and
dimers (from Blundell et al., 1972; reproduced with permission of
Academic Press, Inc.).
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of insulin secreting beta cells is mediated by the immune system
(Pyke, 1989). Ultimately, addressing the problem of autoimmunity
my lead to a different way to treat and even cure diabetes, but that
area of research is new and relatively unexplored, so for the time
being attention must be given to optimizing the currently available
treatment.
1.3.1 Traditional Injection Therapy.
For insulin dependent patients (Type I diabetes), the classical
method of achieving glycemic control is via subcutaneous or
intramuscular injections of concentrated insulin preparations
(Brange, 1987). The preferred regimen is based on twice daily
injections -- before breakfast and at bedtime. Mixtures of short,
intermediate and long acting (slowly dissolving) insulins are used to
counteract the increased blood sugar content at meal times and to
maintain a basal insulin concentration between meals.
Unfortunately, the insulin profile generated is far from physiological
(Figure 1.3): the slow rise to peak concentrations causes post-
prandial hyperglycemia, and the slow return to baseline
concentrations may result in hypoglycemia between meals (Home et
al., 1989). Other problems are caused by variable insulin adsorption
and dispersion rates, variable dissolution rates for the long acting
insulin-protamine complexes, disruption of subcutaneous tissue and
night-time hypoglycemia. The differences in patient behavior,
metabolism, eating habits and physical exertion, further complicate
the administration of insulin preparations (Home et al., 1989; Brange
et al., 1990).
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Figure 1.3: Typical profiles of normal and diabetic plasma insulin
levels after a meal at time 0 (adapted from Brange et al., 1990).
1.3.2 Alternative Treatments of Diabetes
Despite the problems associated with traditional injection
therapy, subcutaneous administration remains the most efficient way
to deliver insulin solutions to the patient. Enzymatic degradation
prevents oral insulin administration, as most of the drug is
metabolized prior to reaching the bloodstream. Chemically modified
gell-encapsulated insulins are currently being investigated (Sato et
al., 1984); these systems are "based on the competitive binding of
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glucose and derivatized carbohydrate-coupled insulin to
Concanavalin A; the glycosylated insulin is displaced from Con A by
glucose in response to, and proportional to," blood glucose levels
(Jeong et al., 1984).
Slow transdermal diffusion prevents topical administration of
insulin, making nasal, rectal, buccal and sublingual delivery routes at
best 50% as effective as intramuscular injections (Aungst et al.,
1987), although some aerosol dosages have been proposed (Lee and
Sciarra, 1976). Recently, iontophoresis has been used to facilitate
transdermal transport of insulin (Siddiqui, 1987), but with limited
success (90 minutes required to deliver 1/2 required dose) and only
on animal models. Transplantation of neonatal rabbit pancreatic
tissue (Gates and Lazarus, 1977) and insulin encapsulation in
erythrocytes (Bird et al., 1983) have also been attempted, but proved
not to be clinically useful.
During the past decade, advances have been made in the
development of artificial pancreas and pancreatic transplantation,
and much research has been devoted to the development of self-
regulating artificial infusion and controlled release systems (Home et
al., 1989). Unfortunately, the initial enthusiasm about the
implementation of these novel treatments has subsided due to the
high cost and technical difficulties surrounding the transplantation
procedures (Pyke, 1989), while the self-monitoring infusion pumps
are proving to be cumbersome, difficult to control, and subject to
problems related to insulin aggregation (Home et al., 1989);
Lougheed et al., 1980; James et al., 1981; Lougheed et al., 1983).
Pancreatic transplantation remains a rare and drastic treatment with
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a success rate of 40-50% (Home et al., 1989), and the majority of
insulin infusion pumps (both subcutaneous and intravenous) are
limited to clinical use. Furthermore, insulin infusion pumps have not
shown. significant improvements over the more common insulin
injection therapy (Leichter et al., 1985).
An alternative method of insulin administration is controlled
release of the hormone from polymer matrices. The development of
such devices is still in experimental stages because the problems of
insulin stability within the polymer and regulation of the release
rates have not been resolved (Creque et al., 1980; Brown et al.,
1986). The only new device which is gaining widespread use is the
pen injector, which combines the insulin vial and syringe with a dose
measuring device (Home et al., 1989). The pen injector may allow
for greater meal-time flexibility, but it has yet to undergo conclusive
clinical trials; further design modifications may be necessary to
accommodate the resuspension of complexed insulin preparations.
Although the portable pen injector offers the patient greater
convenience and flexibility, it does not differ fundamentally from the
traditional injection therapy, and will be subject to some of the same
problems.
1.3.3 Changes in Pharmaceutical Formulations.
Despite numerous efforts to improve diabetes therapy, the
regulation of blood glucose levels has changed very little since the
original introduction of insulin injections. While the methods of
insulin administration have remained more or less the same, the
quality of insulin preparations has increased dramatically because of
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improvements in isolation and purification techniques (Brange,
1987).
Acidic preparations of insulin were required to solubilize the
impure form of the hormone available initially; neutral formulations
(which were more stable and better tolerated by the patients) were
made possible only in the 1960s (Brange, 1987). In addition to these
rapid-acting insulins, formulations designed to prolong insulin effects
were introduced in the 1930s (Hagedorn et al., 1936). The
protracted action was achieved by complexing insulin with
protamine or other basic peptides which depressed insulin solubility
at neutral pH; similarly long-acting Zn-insulin suspensions were
developed at NOVO labs in the 1950s (Brange, 1987). Mixtures of
short and intermediate acting formulations could be used to
counteract the glucose challenge at meal times and to maintain a
basal insulin level between meals.
Traditionally, the hormone was isolated from bovine and
porcine sources; animal derived protein formulations proved to be
compatible with the majority of insulin-dependent diabetics,
although some patients were allergic to such preparations. In recent
years, concern about insulin availability led to the development of
recombinant human insulin which assured unlimited supply and
improved compatibility (reduced antigenicity) (Johnson, 1983).
1.4 Goals and Motivation
To improve the treatment of diabetes, novel methods of insulin
administration are needed. New therapies capable of providing a
more physiological response to blood glucose levels could improve
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the diabetics' quality of life and reduce the risk of microvascular
renal and retinal complications (Home et al., 1989). The design and
implementation of all drug delivery systems must take into
consideration the delicate nature of the hormone, and steps must be
taken to improve stability of insulin formulations. While some
causes for physical, chemical and biological instability of insulin have
been identified (Lougheed et al., 1980; Grau, 1985; Brange et al.,
1987) and some stabilizing agents have been partially successful (see
chapter 2), the pathways and kinetics of insulin aggregation have not
been unequivocally determined. Rather than continue an empirical
investigation of destabilizing/stability enhancing additives, this
project addressed the fundamental nature of insulin aggregation.
The ultimate goal of this study was the design of rational
stabilization strategies based on a basic understanding of insulin
behavior in solutions and a clear picture of the aggregation
mechanism.
1.5 Overview of Thesis
In this study, a rigorous kinetic analysis was used to
investigate the mechanism of insulin aggregation. Time-dependent
concentration profiles were obtained by monitoring the levels of
non-aggregated insulin remaining in o.olution (UV absorbance at 280
nm), and changes in particle size distribution were determined using
quasielastic light scattering (QELS). The experimental set-up allowed
for a systematic study of the parameters affecting insulin behavior in
aqueous solutions. Possible reaction mechanisms were formulated
based on the overall kinetic pattern and information about insulin's
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physical and chemical properties available in the literature. To
determine the validity of proposed reaction schemes, mathematical
models of possible reaction pathways were constructed, and results
of computer simulations were compared with empirical evidence.
The proposed mechanism included insulin's self-association
into dimers and hexamers, the interactions with hydrophobic
surfaces and the formation of stable intermediate species. The model
successfully predicted trends in insulin aggregation as well as the
effects of some external perturbations. It identified monomer
destabilization at hydrophobic surfaces as one of the main pathways
leading to aggregation. Stabilizing additives which prevent
unfavorable conformational changes by excluding insulin from the
hydrophobic interface, were shown to dramatically increase insulin
solution stability. The mathematical model presented here served
two purposes: it clarified the aggregation mechanism, and suggested
rational stabilization strategies. Hopefully, a better understanding of
insulin aggregation can eventually contribute to improvements in
diabetes therapy.
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CHAPTER 2.
BACKGROUND
2.1 Insulin Structure and Conformation
Most proteins' biological functions depend on their native
conformations. Insulin's ability to recognize and bind to its receptor,
thus signalling the need for glucose metabolism, is closely linked to
its folded, three-dimensional structure. The role of native
conformation in this regulatory mechanism has long been recognized,
and much effort has been devoted to elucidating not only the amino-
acid sequence, but also the spacial orientation of the residues making
up this protein.
2.1.1 Crystal Structure
Insulin's ability to crystallize in the presence of Zn2 + has been
known since the early 1930s; during the 1960s, several groups have
investigated insulin's crystalline structure by X-ray diffraction
(Blundell et al., 1972), revealing the three-dimensional orientation of
the amino-acid sequence. Crystalline systems of hexamers and
dimers have been elucidated, as have the monomeric crystals of beef
and sheep DPI (despentapeptide) insulins (native insulin monomers
self-associate to dimers and hexamers at concentrations required for
crystallization) (Derewenda et al., 1989b). Since the Zn-insulin
hexamer crystals are the naturally occuring species used for insulin
storage in the pancreas, the following discussion will be restricted to
their structure.
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The shape of insulin hexamer crystalls depends on the
concentration of Zn2 +, Ca2 + and phenol. In the presence of Zn2 + ,
insulin hexamers form nearly-symmetric (2 Zn2 +) and assymetric (4
Zn 2 +). rhombohedral crystals; hexamers containing 2 Zn2 + and a
phenol molecule form symmetric monoclinic crystals (Derewenda et
al., 1989a). Although crystal geometry varies with insulin species,
pH and zinc content, hexamerization produces "an almost spherical,
very stable structure with a largely polar surface, and very suitable
for crystal formation. In all likelihood it has evolved in response to
the advantages that crystal deposits represent in storage"
(Derewenda et al., 1989b) (Figure 2.1). Recent studies have
examined insulin-metal ion interactions, binding affinities and rates
(Coffman and Dunn, 1988). The contributions of Zn 2+ and Ca2+ to
insulin hexamer assembly, stability and storage have also been
investigaed (Hill et al., 1991).
For years, protein chemists have hypothesized that a protein's
conformation in aqueous solution was the same as its crystalline
structure. Thanks to the advances in two-dimensional NMR
technology, that assumption can now be tested: insulin's
conformation in solution has recently been determined, and was
found to be nearly identical to that in the crystalline state (Weiss et
al., 1989; Kline and Justice, 1990). The investigations of insulin's
solution stability can now safely draw upon the wealth of structural
information available from X-ray diffraction studies.
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Figure 2.1: Structure of the Zn-insulin hexamer. Jagged lines
between monomers on the top and bottom of the hexamer indicate a
dimer-dimer interface. Straight lines between monomers on the top
and bottom of the hexamer indicate a monomer-monomer interface
within a dimer. The "hash marks" indicate the top of monomers.
Zn 2+ ions are shown on the 3-fold axis in the positions they occupy in
two-zinc insulin. Each of the zinc ions is coordinated by three His
(B10) side chains and by three water molecules (adapted from Hill et
al., 1991; used by permission of the American Chemical Society).
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2.1.2 Insulin's Self-Association in Aqueous Solutions
Insulin's ability to form dimers and hexamers has long been
recognized, and its equilibrium self-association pattern has been the
subject of numerous studies. Insulin's association state has been
investigated by sedimentation equilibrium studies as early as 1953
(Fredericq, 1953). Equilibrium ultracentrifugation remained the
instrument of choice for researchers examining insulin's self-
association pattern; from the observed diffusion coefficients,
molecular weights, degrees of association and various
thermodynamic parameters (AGo, AH° and AS') could be determined.
The accuracy of early investigations may have been compromized by
impurities (such as proinsulin), but the general trends in association
behavior are in good agreement with more recent studies.
Jeffrey and Coates examined bovine insulin's self-association at
pH 2 and various ionic strengths and temperatures (Jeffrey and
Coates, 1966a&b), finding increased ionic strength to favor dimer and
hexamer formation; they also reported the prevalence of the insulin
dimer, which they attributed to its high association constant. Self-
association of porcine insulin and proinsulin at neutral pH was also
investigated, and the results fitted to a model involving monomer,
dimer and hexamer formation (Pekar and Frank, 1972). The degree
of association was found to be higher at neutral than acidic pH even
in the absence of Zn2 +, and proinsulin's self-association was reported
to be similar to that of insulin (Pekar and Frank, 1972). Bovine Zn-
insulin's oligomerization was compared with Zn-free insulin; a higher
proportion of high molecular weight species was reported in the
presence of 2 g-atoms of Zn2 + per insulin hexamer, and glucose was
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shown to favor dissociation (Jeffrey, 1974). The self-association
pattern of bovine Zn-free insulin at pH 7 and room temperature was
further investigated, and equilibrium constants for the formation of
dimers, hexamers and higher molecular weight species were
determined (Jeffrey et al., 1976). A similar analysis was done for
bovine Zn-insulin at pH 7 (25 0C, ionic strength 0.2) (Milthorpe et al.,
1977), and Zn-free bovine insulin at pH 7.4 (200 C, ionic strength
0.368) (Holladay et al., 1977). The technique of concentration
difference spectroscopy was used to determine the equilibrium
association constants for bovine and porcine Zn-free insulin and
proinsulin (at pH 2 and 7, 25 0C) (Strazza et al., 1985). Although the
general trends reported in the above study were in good agreement
with previous investigations, the constants based on concentration
difference spectroscopy deviated from values reported by others.
This could probably be explained by the inappropriateness of the
assumption that in the absence of Zn 2 +, insulin would not form
hexamers even at neutral pH. The results of equilibrium self-
association studies are summarized in Table 2.1.
A mathematical model describing self-association of Zn-free
bovine insulin at acidic, neutral and basic conditions was proposed
recently (Mark et al., 1987); a revised version incorporated four
different patterns of association (Figure 2.2) and effects of non-
ideality (Mark and Jeffrey, 1990). Model 1 assumed that one
association constant could be used to describe insulin oligomerization,
which proceeded by "head-to-tail" addition of monomers and
resulted in an equilibrium of odd- and even-numbered species.
Model 2 proposed that dimerization was followed by a
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Figure 2.2: Diagrammatic representation of 4 model patterns for
insulin self-association used in determining equilibrium association
constants (adapted from Mark and Jeffrey, 1990). Each circle
represents the insulin monomer; different shades are used to
distinguish between the dimer- and hexamer-forming regions of the
assymetric molecule. Please see text for more details about these
association mechanisms.
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conformational change which led to subsequent interactions between
dimers only. Model 3 defined two association constants: one for
"head-to-head" and one for "tail-to-tail" monomer addition; based on
interactions known to occur during hexamer formation in the crystal,
this scheme allowed for the existence of odd- and even-numbered
insulin oligomers in solution. In model 4 (the mechanism used by
Pekar and Frank), dimerization was governed by one association
constant, while the constant for hexamer assembly from three
dimers was assumed to be so high as to render intermediate species
(tetramers) virtually nonexistant. The authors commented on the
usefulness of various models and concluded that while no preferred
(uniquely correct) pattern can be established at this time, "it is better
to use one' of the models...than none at all" (Mark and Jeffrey, 1990).
2.1.3 Structure of Insulin Aggregates
A certain amount of confusion exists in the literature about the
term "aggregate", which in the case of insulin has been used to
describe both the products of equilibrium self-association (dimers,
hexamers, etc.), and the high molecular weight, biologically inactive
species. This investigation reserves the term "aggregation" for the
non-covalent association between partially denatured insulin
molecules, which leads to the formation of large, inactive
agglomerates. Dissolution of these aggregates requires extreme
conditions (pH>10, 6 M GdHCI or Urea), and recovery of biological
activity is questionable. In contrast, the oligomeric species formed
by equilibrium self-association, readily dissociate to the monomeric
state and retain full biological activity upon dilution at physiological
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conditions.
The chemistry of aggregate (or fibril) formation was
investigated by Waugh in the 1950s, who induced destabilization by
repeatedly heating and freezing acidic solutions of insulin (Waugh et
al., 1953). Under these conditions, aggregation was found to be
reversible, leading to the conclusion that the fibrils were formed by
hydrophobic interactions between slightly altered conformations of
native insulin molecules (Waugh, 1955). The reaction was reported
to be autocatalytic: small concentrations of insulin fibrils added to
previously unperturbed solutions, nucleated aggregation,
progressively depleting the concentration of soluble protein (Waugh
et al., 1953). Electron microscopy and X-ray diffractions studies
indicated that "the fibrils are composed of polypeptide chains which
are in the 8 conformation and which extend transverse to the fibril
axis (i.e., cross-J structure)" (Burke and Rougvie, 1972). The role of
hydrophobic interactions was emphasized once again: "extensive
interactions involving nonpolar residues on the surface of the fibrils
serve to protect the interior hydrogen bonding from disruptive
effects of polar solvents" (Burke and Rougvie, 1972).
Although insulin aggregation in pharmaceutical preparations is
observed under much less stringent conditions (neutral pH, mild
agitation and only slightly elevated temperatures), and leads to
precipitation rather than gel-like structures, the basic elements
involved are independent of the macrostructure (Brange et al., 1987).
Increased concentrations of insulin monomer have been shown to
accelerate the fibrillation process, indicating that aggregation
involves partially denatured monomeric species (Brange et al., 1987).
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In the fibrills, the antiparallel R-pleated sheet structure involved in
dimer formation, is replaced by a parallel arrangement, which
increases the hydrophobic surface area and provides additional sites
for hydrophobic interactions (Brange et al., 1987).
The information about structural properties of both native and
aggregated insulin species provides invaluable insights for the
formulation of a physically reasonable mechanism of destabilization.
2.2 Previous Investigations of Insulin Stability
Stability and efficacy of insulin formulations is a serious
concern for diabetic patients, their doctors, pharmaceutical
companies and students of protein chemistry. It comes as no
surprize that the stability of this medically significant protein has
been the subject of numerous investigations.
2.2.1 Stability of Insulin Crystals
In the absence of water, insulin is remarkably stable.
Crystalline preparations of insulin (5-6 wt% water content) stored at
-20 0 C for over 20 years retain >99% of their original activity (Storring
et al., 1975; Fisher and Porter, 1981). Loss of potency is accelerated
by elevated temperatures, yet even after being stored at 370C for 14
years, the preparations retained ~70% of original activity (Storring et
al., 1975).
2.2.2 Stability of Insulin Solutions (Static Storage)
In aqueous solutions, insulin stability decreases drastically
(compared to dry storage of insulin crystals): the population of
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native insulin is reduced by deamidation and aggregation (formation
of high molecular weight polymers which do not redissolve at neutral
pH) (Grau, 1985). While desamido insulin retains biological activity,
the aggregates are largely responsible for the loss of potency of
insulin preparations in a variety of delivery environments (Lougheed
et al., 1983; Grau, 1985). Earlier studies have shown that neutral
regular insulin solutions are more stable than acidic preparations:
upon storage at 5PC, neutral solutions were stable for over 4.5 years,
while acidic solutions were stable for only 2 years (Jackson et al.,
1972). Elevated storage temperatures accelerated insulin
degradation, deamidation being more pronounced in the acidic
preparations. No concentration dependence was observed, and
biological potency was shown to be a function of time and
temperature only (Pingel and Volund, 1972). Despite the claim that
neutral commercial preparations are stable for more than 4 years,
"frosting" or "hazing" of refrigerated insulin solutions accompanied
by a marked loss of biological potency has been recently reported by
diabetic patients (Benson et al., 1988). Thus, insulin aggregation
remains a problem even under the most favorable conditions: static
storage at low temperatures.
The gain more insights into protein solution behavior,
denaturation of insulin and proinsulin induced by guanidine
hydrochloride was investigated using near- and far-ultraviolet (UV)
circular dichroism (CD) (Brems et al., 1990). Denaturation was found
to be a two state transition, with a Gibbs free energy of unfolding of
4.5±0.5 kcal/mol.
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2.2.3 Solution Stability in Artificial Infusion Systems
Insulin aggregation presents serious problems for prolonged
artificial infusion systems. In a portable or implanted insulin pump,
highly. concentrated insulin solutions are exposed to elevated
temeratures (25-37 0C), continuous motion, and a large surface
contact area in small diameter tubing and catheters. Untreated
insulin solutions remain stable for 1-3 days, and must be replaced to
prevent aggregation and occlusion of delivery passages. Inconsistent
aggregation patterns make it difficult to maintain a stable basal
glucose level in diabetic patients relying on this method of drug
administration.
The work of Pickup and co-workers stimulated more than a
decade of attemps to perfect portable continuous infusion systems
which promised to provide improved glycemic control: a dual rate
pump could maintain a basal insulin concentration between meals
and provide an increased infusion dose before and during meals to
counteract elevated glucose levels (Pickup et al., 1978). Early studies
indicated that insulin dependent diabetics using such devices
exhibited near-normal metabolism resulting from stricter regulation
of blood glucose concentrations (Pickup et al., 1979; Nathan, 1982).
The initial enthusiam began to subside as technical problems with
the pumps became apparent: long-term glycemic control was
compromized the instability and aggregation of insulin formuations
(Irsigler and Kritz, 1979). Many researchers attempted to identify
the causes of instability and to delay the onset of aggregation in
order to make the artificial infusion systems more feasible.
Lougheed and co-workers reviewed the effects of purity, metal
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ions, temperature, motion and other physical, chemical and
thermodynamic factors influencing insulin aggregation (Lougheed et
al., 1980). Destabilization was attributed primarily to elevated
temperature, agitation, and the presence of impurities/man-made
materials in contact with insulin solutions. The studies that followed
observed insulin aggregation under conditions mimicking the
artificial infusion environment: solutions containing a variety of
additives and pump materials were agitated at 37-50 0C and stability
was measured by the presence or absence of visible micron-sized
agglomerates. Many potential stabilizing reagents were tested:
autologous serum (Albisser et al., 1980), bicarbonate ion (Lougheed
et al., 1981), lysine, aspartic and glutamic acid (Bringer et al., 1981;
Quinn and Andrade, 1981), EDTA (James et al., 1981) and glycerol
(Blackshear et al., 1983) slightly prolonged the lifetime of insulin
solutions, but were not adequate for long-term use.
Another comprehensive study examined the effects of
physiological and synthetic surfactants on insulin aggregation, and
identified some pump materials (i.e. silicone rubber) which
significantly accelerated the degradation reaction (Lougheed et al.,
1983). Some of the surfactants (SDS, Brij 35, Tween and Triton X)
were shown to maintain solution stability for up to 150 days, but
were required at concentrations which were unphysiological. The
same investigation suggested that insulin's interactions with solid-
liquid and liquid-air interfaces possibly contributed to aggregation
by inducing partial conformational changes in the protein. Increased
stability at higher concentrations was also reported, but no adequate
explanation was provided for this unusual behavior (Lougheed et al.,
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1983). A similar concentration dependence was observed and
increased stability in the presence of small amounts of Ca2 + was
found at NOVO labs (Brange and Havelund, 1983).
A correlation between the nature of contact material and
aggregation rates was also observed: hydrophilic materials (e.g.
cellulose butyrate) were shown to be much more compatible with
insulin solutions, while hydrophobic ones (polypropylene and
polyvinylchloride) increased insulin's propensity to aggregate
(Feingold et al., 1984; Chawla et al., 1985). Solution stability was
found to depend not only on the polymer used, but on the
sterilization method used for the material: gamma irradiated
polymers were shown to be particularly deleterious to insulin
solutions (Melberg et al., 1988). Others reported that insulin was
more stable in polyethylene than glass reservoirs, and that chemical
and physical transformations occured in passage through the
pumping mechanism tubing and catheters (Selam et al., 1987).
The influence of physical parameters on insulin aggregation did
not escape the researchers" scrutiny: low flow-rates in infusion
pumps were shown to reduce solution stability (Brennan et al.,
1985). Aggregation was also attributed to high shear-rates in tubing
and needles (Hutchison, 1985) and the volume of air in contact with
protein solutions (headspace in agitated insulin vials) (Hansen et al.,
1987).
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2.2.4 Insulin Stability in Controlled Release Polymer
Matrices
Many of the aggregation inducing parameters were absent in
polymeric controlled release devices. High concentrations of insulin
were loaded into the matrix, preventing dissolution within the device
(Brown et al., 1986). Interfaces with air were absent, and agitation
effects could be eliminated, since the protein remained in its dry
form. However, the devices were exposed to elevated temperatures
(370 C), and as the dissolved insulin diffused out of the matrix, it
came in contact with hydrophobic polymer surfaces. An additional
complication was the moisture content of the device, which probaby
increased after implantation. One or a combination of these factors
led to insulin aggregation, and prevented the release of 37-40% of
the incorporated protein (Brown et al., 1986).
The nature of insulin aggreg, as inside the polymer marix
remains unclear. If covalent interactions are involved, then the
destabilization could be similar to moisture induced aggregation of
BSA (which was shown to result from intermolecular S--S bond
formation via the thiol-disulfide interchange reaction (Liu et al.,
1991)). The addition of inorganic salts, lyophilization from acidic
aqueous solutions, and co-lyophilization with water soluble polymers
minimized BSA's solid-state aggregation (Liu et al., 1991); similar
approaches to reduce insulin's moisture induced aggregation are
currently being investigated in Dr. Langer and Dr. Klibanov's research
groups.
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2.2.4 Insulin Adsorption
Poteins' interactions with solid surfaces have often been found
to cause losses in biological activity (Mizutani, 1979). Addition of
excess. amount of BSA (which preferentially adsorbs to glass and
other container materials) is usually suggested to decrease protein
binding and subsequent unfavorable reactions (e.g., denaturation and
aggregation).
Insulin was shown to bind to glass, especially at low (10-10 M)
concentrations (Cuatrecasas and Hollenberg, 1975). Various plastics
(polythene, siliconized glss, nylon, teflon, cellulose nitrate and parafin
wax) were found to bind >50% of insulin in solutions containing
physiological concentrations (10- 9 to 10-11 M) of the protein;
adsorption was attributed to non-covalent interactions between
insulin's hydrophobic groups and the hydrophobic plastic surfaces
(Cecil and Robinson, 1975). Insulin's conformational change prior to
adsorption was thought to be responsible for the slow binding rate,
and coating the containers with cetyl alcohol was found to
significantly reduce adsorption at these low concentrations (Cecil and
Robinson, 1975).
Insulin's susceptibility to denaturation and loss of activity upon
binding to glass was found to be greatly reduced at higher
concentrations (0.17 mM); in fact, unlike horse-radish peroxidase,
alkaline phosphatase and catalase, which lost 52, 86 and 98% of
activity, respectively, after 3 months of adsorption to porous glass at
40C, insulin's activity declined by less than 11% (Mizutani, 1979).
Adsorption to various polymeric materials used in artificial infusion
devices was shown to be reduced by urea (1-3 mg/ml) (Sato et al.,
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1983), and insulin was found to bind preferentially to hydrophobic
surfaces (siliconized glass and polyvinylchloride), once again
suggesting the possibility of hydrophobic interactions between
insulin's moieties and container materials (Asakawa, 1984).
A comprehensive study of insulin adsorption isotherms on
Teflon, silastic, glass, polyacrylamide, and polystyrene in phosphate
(pH 7.4) and acetate (pH 3.5) buffers and at 23 and 37 0C, provided a
rigorous quantitative relationship between insulin concentration and
surface binding (Sefton and Antonacci, 1984).
Increased adsorption was observed in monomeric solutions of
insulin (Jeffrey, 1986), while Zn-insulin binding to hydrophillic metal
surfaces was attributed to deposition of hexamers, rather than the
more hydrophobic monomers and dimers (Arnebrant and Nylander,
1988). Insulin adsorption and interactions between layers bound to
hydrophobic surfaces were recently examined using a surface force
apparatus (Claesson et al., 1988). And yet, the relationship between
adsorption and aggregation remains speculative.
2.3 Proposed Mechanisms of Insulin Aggregation
Despite the large number of studies conducted to examine
insulin stability, little is known about the kinetics of aggregation.
Several pathways have been suggested based on the qualitative
observations and stabilizing trends: Lougheed and co-workers
proposed a competitive inhibition mechanism which addressed the
phenomenon of increased stability at higher concentrations
(Lougheed et al., 1983), while Thurow and Geisen speculatea on the
role of interfacial interactions on insulin aggregation (Thurow and
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Geisen, 1984).
The competitve inhibition mechanism assumed that aggregate
formation began with partial unfolding of insulin monomers; through
non-covalent interaction, these destabilized specied formed high
molecular weight polymers. Since this process involved partially
unfolded molecules, the concentration of unaltered monomers was
expected to competitively inhibit the interactions between the
denatured species (Lougheed et al., 1983). Increased stability of
insulin solutions at higher concentrations was attributed the the
higher concentration of native species. However, this mechanism
neglected the fact that although a smaller proportion of insulin
molecules remained monomeric as concentrations 'acreased, the
absolute number monomers increased with total concentration. If
aggregation was initiated by partial denaturation of insulin
monomers, the driving force for the reaction would still increase with
concentration, even if relative amount of susceptible molecules
decreased.
The second mechanism addressed the problem of insulin
denaturation at interfaces. The dimer was assumed to preferentially
adsorb and partially denature at hydrophobic surfaces, where high
molecular weight aggregates formed in the adsorbed layer (Thurow
and Geispn, 1984). Two stabilizing strategies implied by this model
were 1) elimination of hydrophobic surfaces in contact with insulin
solutions, and 2) stabilizing reagents favoring hexamer formation,
which would reduce the dimer population. While this kinetic scheme
pointed out important destabilizing interactions, it did not provide an
adequate description of insulin aggregation behavior. Ample
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evidence suggested that insulin aggregation was initiated by the
monomer and not the dimeric species. This mechanism also failed to
explain increased solution stability at higher insulin concentrations.
Both reaction schemes attempted to provide qualitative explanations
for experimenatlly observed trends, but neither successfully
described the dynamics of insulin aggregation.
2.4 Current Stabilization Strategies
Once the causes of insulin aggregation became apparent,
researchers attempted to eliminate, or at least modify, the
destabilizing interactions.
2.4.1 Design of Stability Enhancing Additives
Despite the large number of investigations addressing the
problem of insulin stability in artiticial infusion devices, the
mechanism of degradation remained speculative. Scientists at
Hoechst proposed that aggregation was initiated by insulin's
adsorption to and denaturation at hydrophobic surfaces; their
stabilizing reagent Genapol PF-10 (a polypropylene
glycol/polyehtylene glycol block co-polymer) was aimed at
preventing insulin adsorption to solid surfaces (Thurow and Geisen,
1984). Increased solution stability was attributed to the fact that
Genapol contained both hydrophobic and hydrophilic portions. The
hydrophobic regions would bind to glass, while the hydrophilic
groups extended into the solution, effectively reducing the
hydrophobic surface area exposed to insulin solutions. In-vitro and
in-vivo studies with implantable infusion devices containing Genapol
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PF-10 stabilized insulin solutions were quite successful, with an
average of 90% of insulin retaining activity for up to 5 months (Grau
and Saudek, 1987). Pluronic F68 (a similar polypropylene
glycol/polyehtylene glycol block co-polymer) was also reported to
prevent insulin aggregation in samples agitated for 8 days (Chawla et
al., 1985).
The recognition that the insulin hexamer had a very stable
protein conformation, promted attempts to design additives which
would favor hexamer formation. Solution stability was shown to be
increased by the addition of Zn 2 + (Brange et al., 1986), and phenol
was reported to stabilize hexamer's helical structure (Derewenda et
al., 1989a). Others tried to design reagents or ligands aimed
specifically at hexamer stabilization (Manallack et al., 1985),
(McGraw et al., 1990). The roles of Ca2 + and Zn2+ in hexamer
assembly and stability were also investigated recently (Palmieri et
al., 1987), (Hill et al., 1991). However, it is important to remember
that while hexamer stabilization may reduce the risk of aggregation,
it may adversely affect insulin absorption, since dissociation to the
monomeric state is necessary prior to entrance into the bloodstream
(Brange et al., 1990). Rather than improving the quality of insulin
preparations, increased hexamer stability may dely the 'response to
elevated blood glucose levels, making normoglycemia even more
difficult to achieve.
2.4.2 Chemical Modifications of Insulin Structure
Another approach to increasing insulin stability was through
chemical modification of the protein. Since aggregation was thought
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to occur via hydrophobic interactions of partially denatured
molecules, various modifications/mutations could be introduced to
reduce hydrophobicity of exposed surfaces. Sulfated insulin (SI),
used to treat diabetics with crystalline zinc-insulin intolerance, does
not self-associate at neutral pH due to the electrostatic repulsion
imparted by the SO042- groups. SI solutions used in in-vivy studies
with portable infusion pumps, remained stable for 140 days and
provided adequate glycemic control in pancreatomized dogs (Nomura
et al., 1983). Despite the fact that SI was shown to be resistant to
aggregation in artificial delivery environments, it did not become a
substitute for zinc insulin; concerns about its antigenicity and
receptor binding (as well as the cost associated with the sulfation-
sulfonation procedure) probably imposed limitations on its
widespread use (Pongor et al., 1983).
Other structural modifications were attempted to prevent
insulin self-association and aggregation. Most changes were
accompanied by reduced biological potency, even if they succeeded
in improving stability (Carpenter et al., 1980). Efforts to engineer
monomeric insulins (Bi et al., 1984; Brange et al, 1988) for better
absorption profiles met with some success: some of the modified
insulins exhibited equal or higher biological potency (Schwartz et al.,
1989), but physical stability was reduced (Brange et al., 1990). The
changes which prevented insulin monomer's association into dimers
and hexamers actually increased its propensity to aggregate.
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2.5 Conclusions
The medical significance of insulin prompted numerous
researchers to examine its physical, chemical and biological
properties, making it one of the most thoroughly investigated and
characterized proteins to date. Studies of insulin paved the way for
exploring the biochemistry of other proteins and enzymes. It
seemed that every aspect of insulin structure and function had
undergone compelete and exhaustive analysis, and yet, insulin's
tendency to aggregate had not been fully explained. This work
aimed to combine the information obtained by previous investigators
with an original kinetic analysis in order to elucidate the pathways of
insulin's instability and aggregation.
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CHAPTER 3.
EXPERIMENTAL APPROACH
3.1 Introduction
To study the fundamental nature of insulin aggregation, it was
necessary to have:
a) control of the aggregation process (the ability to achieve
rapid, reproducible aggregation, and to vary parameters responsible
for destabilization; and
b) quantifiable analytical methods (the ability to monitor
aggregation kinetics, determine the nature of association, and
identify native and intermediate species involved in aggregate
formation).
While insulin aggregation rates could be controlled by changing
such physical parameters as temperature, agitation rates, and
hydrophobicity of surfaces in contact with insulin solutions, analysis
of protein behavior presented a more challenging problem. The
desired analytical technique had to detect changes in native
conformation, and be able to identify and quantify the species
involved in the aggregation reaction, all without interfering with the
protein. The methods best suited for kinetic studies had to be rapid
as well as quantitative and non-invasive. To determine which
analytical tools were most appropriate for this work, a literature
review was done to examine the advantages and drawbacks of
various techniques.
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3.1.1 Analytical Methods Used in Previous Studies
In the investigations reviewed in Chapter 2, the presence of
aggregates and native insulin species was monitored by a variety of
experimental techniques:
1) visual inspection for turbidity {physical stability} (Lougheed
et al., 1980; Lougheed et al., 1983)
2) absorbance at 540 and 600 nm {physical stability}
(Lougheed et al., 1983)
3) ultracentrifugation {sedimentation experiments to determine
insulin's self-association state} (Jeffrey, 1974; Pekar and Frank,
1972)
4) circular dichroism (CD) {changes in helical content
representative of conformational changes} (Pocker and Biswas,
1980; Svao et al., 1983; Truskey et al., 1987)
5) reverse-phase High Performance Liquid Chromatorgraphy
(HPLC) {chemical stability}, (Chance et al., 1981; Grau, 1985;
Arakawa et al., 1989; Adams and Haines-Nutt, 1986; Fisher and
Smith, 1986)
6) size-exclusion HPLC {chemical stability} (Schrader and
Pfeiffer, 1985a&b; Brange et al., 1990)
7) gel electrophoresis {chemical stability, aggregate size}
(Lougheed et al., 1980; Brown, 1983)
8) differential gel adsorption {self-association} (Helmerhorst
and Stokes, 1986)
9) concentration difference spectroscopy {self-association}
(Strazza et al., 1985)
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10) scanning electron microscopy (SEM) {aggregate size} (Sato
et al., 1983; Lougheed et al., 1983)
11) radioimmunoassays (RIA) {biological activity} (Lougheed et
al., 1983; Musial et al., 1986)
12) in-vivo blood glucose levels {biological activity} (Jackson et
al., 1972; Albisser et al., 1980; Benson et al., 1988; Maislos et
al., 1988)
13) 1H nuclear magnetic resonance (NMR) spectroscopy {metal
binding and equilibrium self-association} (Ramesh and
Bradbury, 1986; Ramesh and Bradbury, 1987; Palmieri et al.,
1987; Weiss et al., 1989; Kline and Justice, 1990)
14) quasielastic light scattering (QELS), or dynamic light
scattering, or photon correlation spectroscopy {diffusion
coefficient and hydrodynamic radius determination}
(Martindale et al., 1982; Bohidar and Geissler, 1984; Bohidar,
1989; Dathe et al., 1990)
15) surface force apparatus of Israelachvili {protein-surface
and protein-protein interactions in adsorbed layers} (Claesson
et al., 1988)
16) radiolebelling with 1251 and 6 5Zn {adsorption studies}
(Sefton and Antonacci, 1984; Dathe et al., 1990)
The choice of analytical methods depended on the specific aims
of a particular project. As with other biological molecules, care had
to be taken to prevent denaturation and unfolding during sample
preparation and analysis. No single analytical technique could
provide a complete picture of insulin behavior; ideally, the results of
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several complementary analyses were used the describe the
experimental system.
3.2 Experimental Approach and Choice of Analytical Tools
Only a few of the above mentioned techniques satisfied the
requirements of the proposed kinetic analysis. Optical density
measurements and circular dichroism were found lack specificity;
reverse-phase HPLC, differential gel adsorption and gel
electrophoresis interfered with insulin's native conformation and
self-association equilibrium; ultracentrifugation and NMR
spectroscopy required long equilibration times; concentration
difference spectroscopy would be ill applied to systems containing
more than two association states; the small size of native insulin
species and the extremely low concentrations of soluble
intermediates, prevented the use of SEM techniques; and RIA
techniques, which were extremely sensitive at low concentrations,
did not have significant advantages over simpler and quicker
methods, such as size-exclusion HPLC or ultraviolet
spectrophotometry.
To construct time-dependent concentration profiles of
aggregating insulin solutions and to identify the species involved in
the reaction, this work relied on size exclusion HPLC and UV
absorbance measurements at 280 nm (which determined the
concentrations of non-aggregated insulin), and on QELS (which
analyzed particle size distributions and detected the formation of
reaction intermediates). The latter two methods were particularly
attractive because of their rapidity and non-invasiveness, while the
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HPLC analysis provided important information about insulin's
chemical stability.
The experimental approach was to study the effects of
aggregation inducing parameters on the overall kinetic pattern, and
to infer the reaction mechanism. The legitimacy of proposed
schemes was tested by constructing mathematical models of possible
reaction pathways, and comparing theoretical predictions with
empirical evidence. This was an iterative process: the insights
gained about the physical nature of insulin aggregation were used to
refine the mathematical model, until computer simulations were in
reasonable agreement with experimental trends.
3.3 Materials and Methods
3.3.1 Physical Set-up
The experimental set-up was similar to systems used to study
shakeproofness of insulin preparations, as well as the stability of
insulin solutions in artificial infusion devices (Figure 3.1). The
incubating orbital shaker allowed variation and control of
temperature and agitation rates, while air or Teflon spheres in glass
vials containing insulin solutions mimicked the destabilizing
interactions with hydrophobic interfaces present *in many drug
delivery systems. (In a portable pump, air could be eliminated, but
insulin solutions would still come in contact with solid hydrophobic
surfaces.)
Aggregation rates were easily varied by changing insulin
concentrations, the size and nature of materials contacting insulin
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Figure 3.1: A schematic representation of the experimental system
used to study insulin aggregation in aqueous solutions.
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solutions, temperature, agitation rates, and chemical composition of
the solvent. Control of the air-water interface proved to be more
difficult; measurement and characterization of the air-water
interface were hindered by bubble formation and foaming.
Consequently, the air-water interface was replaced with a Teflon-
water interface in order to facilitate characterization, quantification
and modeling of surface interactions,, Like air, Teflon was an inert
and hydrophobic surface, thus protein-surface interactions at the
Teflon-water interface were expected to be very similar to those at
the air-water interface present in vials used in this study (and in the
diabetes injection therapy).
3.3.2 Insulin Solution Preparation
Bovine Zn-insulin (Sigma 15500, lots 38F-0827 {25.6 IU/mg},
128F-0523 {24.4 IU/mg} and 79F-0092 {25.7 IU/mg}, Zn2 + <0.5%
(w/w)) was used without further purification. Phosphate buffered
physiological saline (PBS, pH 7.4, 0.14 M NaCI/0.1% NaN3
preservative) was filtered through 0.45 gm Millipore HV filter
(Millipore Co., Bedford, MA) and degassed. Stock solutions were
prepared by adding Zn-insulin to PBS; the resulting cloudy mixture
was sealed with Parafilm and placed in an incubating shaker (Lab-
Line Orbital Shaker), where it was gently agitated (70 rpm) for 3
hours at 370C. Under these conditions, Zn-insulin dissolved
completely at concentrations up to 0.6 mg/ml. Stock solutions were
sterilized by filtration with 0.22 tm ultra low binding cellulose
acetate bottle filters (Costar, Cambridge, MA). All glassware used in
sample preparation and storage was rinsed with 0.01N HCl and MilliQ
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water, followed by drying at 1000C. Zn-insulin concentrations were
determined by measuring UV absorbance at 280 nm (8 - 5.53 mM-1
cm-1).
3.3.3 Concentration Dependence Studies: Air-Water
Interface
Borosilicate glass HPLC vials (1.1 ml, Sun Vial with
polyethylene cap, Sun Brokers, Wilmington, NC) were acid rinsed and
dried as described above. Each vial was filled with 0.75 ml of insulin
solution of appropriate concentration (0.6, 0.3, or 0.1 mg/ml), capped,
and sealed with Parafilm to prevent leakage. The samples (each
contributing a time point) were taped horizontally to the platform of
the incubating shaker and agitated at 250 rpm and 370 C. (The
importance of shaking speed was examined by agitating 0.6 mg/ml
samples at 120 rpm.) Every 20 minutes, one vial was removed and
the extent of aggregation was determined by size-exclusion isochratic
HPLC analysis (Bio-Sil SEC-125 column from Bio-Rad Laboratories;
mobile phase consisting of 10% acetonitrile and 90% aqueous solution
containing 0.02 M NaH2PO4 and 0.05 M Na2SO4, pH 6.8; flow rate of
1.2 ml/min, detection at 280 and 217 nm). Insulin concentration
was determined by integrating the peak area on the chromatogram.
The decrease in concentration was due to aggregation, whose
manifestation was a change in the physical appearance of the insulin
solution.
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3.3.4 Concentration Dependence Studies: Teflon.Water
Interface
Five Teflon spheres (Polysciences, Inc., #17650), 0.64 cm in
diameter, were placed in each borosilicate glass disposable culture-
tube (12x75 mm, Pyrex) to provide the hydrophobic surface. Insulin
solution (approximately 5 ml) of appropriate concentration (0.6, 0.4
or 0.2 mg/ml) was added to each tube so that there was no
headspace left, and the samples were sealed with Parafilm to
completely eliminate the presence of air (so that the only
hydrophobic interactions would occur on the Teflon surface). The
Parafilm closures were secured with time-labeling tape to prevent
the seals from melting in the incubator. The samples were then
taped horizontally to the platform of the incubating shaker and
agitated at 80 rpm and 370 C. Each sample contributed a time point,
and thus the number of culture tubes depended on the intended
duration of the experiment. Every 30 minutes one sample was
removed from the shaker to measure the progress of aggregation.
The contents of the culture-tube were filtered through sterile 0.8 pm
Millex-PF filters (Millipore) to remove the fully aggregated, micron-
size Zn-insulin particles. The concentration of Zn-insulin remaining
in solution was subsequently determined by absorbance at 280 nm,
and the size distribution of insulin species was determined using
QELS. For each set of conditions, the experiments were repeated in
triplicate.
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3.3.5 Effects of Agitation and Increased Teflon
Surface
To examine the effects of agitation rates and Teflon surface
area on insulin aggregation rates, the number of Teflon spheres was
increased from 5 to 10, and samples were agitated at 80 and 160
rpm. Sample preparation and analysis was as described in section
3.3.4.
3.3.6 Adsorption Studies
To determine the extent of insulin adsorption to glass and
Teflon, several samples (initial insulin concentration of 0.6 mg/ml)
containing 10 Teflon spheres were agitated it 160 rpm and 37 0C
overnight. The fully aggregated samples were removed from the
shaker, and 1.5 ml aliquots from each test tube were transferred to
Eppendorf vials and centrifuged at 14,000xg (Eppendorf micro-
centrifuge, Brinkmann Instruments) for 10 minutes. Insulin
concentrations in the supernatants were determined using
absorbance at 280 nm. The precipitated pellets were resuspended in
1.5 ml of 8 M urea and incubated at 370C for 6 hours. The glass vials
and Teflon spheres were rinsed twice with distilled water; the
spheres were transferred to glass vials containing 2 ml of 8 M urea
and placed in the incubating shaker. One ml of 8 M urea was added
to each of the original culture tubes which were subsequently capped
and placed horizontally in the incubating shaker. Following the
incubation period of 6 hours, insulin concentrations were determined
using absorbance at 280 nm (e =6.0 mM-lcm- 1 for Zn-insulin in 8 M
urea), and size-exclusion HPLC (as described in section 3.3.3).
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3.3.7 Sodium Insulin
Bovine sodium insulin (Calbiochem, lot # 084991, 29.5 USP
U/mg) was used without further purification. Na-insulin solutions
were prepared as described in section 3.3.2, and concentrations were
monitored at 280 nm (e=5.17 mM- 1 cm-1). Kinetic studies were
performed at 370 C and 80 rpm, with 10 Teflon spheres providing the
hydrophobic surface.
3.3.8 Surface Interaction Studies: Solid-Water
Interface
Siliconized glass beads were prepared by immersing glass
beads in siliconizing agent SurfaSil Tm (Pierce # 42800), followed by
drying at 100 0 C for 1 hour. Teflon or polypropylene spheres
(Polysciences, 0.64 cm diameter, 10 spheres per sample), or
borosilicate glass beads (unmodified or siliconized) (Kimble #13500,
0.6 cm diameter, 11 spheres per sample) were added to each
borosilicate glass disposable culture tube (Pyrex, 12x75 mm). All
materials were cleaned by rinsing with 0.01N HCl, followed by
repeated rinsing with MilliQ water and air-drying. Insulin solution
(approximately 4.4 ml) was added to each tube until there was no
headspace left (thus eliminating the hydrophobic interactions at the
air-water interface). Samples were sealed with Parafilm and secured
with time-labelling tape to prevent the seals from melting and
rupturing during the experiment. Samples were taped horizontally
to the platform of the incubating shaker and agitated at 160 rpm and
370 C. Each sample contributed a time point; sampling intervals
varied with the material used: samples with Teflon were analyzed
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every 30 minutes; those with polypropylene and siliconized glass --
every 4 hours for the first 20 hours and every 1 hour thereafter;
samples containing unmodified glass beads were examined once a
day. When a sample was removed from the shaker to determine the
progress of aggregation, its contents were filtered with sterile 0.8 p.m
Millex-PF filters (Millipore) to remove the fully aggregated, micron-
size Zn-insulin particles which interfered with both quasielastic light
scattering (QELS) and ultraviolet absorption spectroscopy (UV)
analyses.
3.3.9 Zn-insulin in Organic Solvents
Zn-insulin was lyophilized from a 1 mg/ml solution (prepared
by dissolving Zn-insulin in MilliQ water (pH 3) and then adjusting the
pH to 7.3). All organic solvents were of analytical grade: DMSO
(Fisher), ethylene glycol (Fisher), and formamide (Fluka).
Lyophilized insulin readily dissolved in the neat organic solvents to
desired concentrations. Zn-insulin concentration was determined by
UV absorbance at 280 nm (e = 8.74, 6.86 and 7.07 mM- 1 cm- 1 for
DMSO, ethylene glycol and formamide, respectively). QELS analysis
could not be performed due to the small difference between the
refractive indices of these organic solvents (n=1.48, 1.43 and 1.45 for
DMSO, ethylene glycol and formamide, respectively) and insulin's
index of refraction (n=1.59); (for aqueous solutions n=1.33). Sample
preparation and experimental conditions were as in air-water
interfacial studies.
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3.3.10 Quasielastic Light Scattering
Light scattering measurements were made using a Lexel argon-
ion laser (model 95-2), with a Brookhaven apparatus consisting of a
goniometer (Model BI-200SM), and a 136-channel digital correlator
and signal processor (Model BI-2030AT), which incorporated an
IBM-ATTM  compatible computer for measurement control, data
accumulation, and particle-size distribution analysis. All
measurements were made with a laser wavelength X=488 nm at a
scattering angle of 900. The latter was particularly useful for
observing Rayleigh scatterers (i.e., particles much smaller than the
wavelength X). Non-aggregated insulin molecules behaved as
Rayleigh scatterers, since the hexamer's 5 nm diameter was small
compared to X. The presence of peaks at diameters >50 nm was
verified at 135 0 , where scattering contributed by dust and rotational
diffusion was minimized (Brookhaven, 1986; Tanford, 1961).
For each sample, light-scattering measurements were
accumulated during 1 minute intervals in order to reduce random
noise in the signal and to ensure a stable baseline. The
experimentally determined autocorrelation function g(r) was used to
obtain the size-distribution function G(y) using inverse Laplace
transform algorithms Non-Negatively Constrained Least Squares
(NNLS) and CONTIN (of Provencher) (Brookhaven, 1986; Stock and
Ray, 1985).
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3.3.11 Computer Simulations
Mathematical modelling of aggregation kinetics was
accomplished by simultaneously solving a set of differential
equations describing each step in the reaction scheme. Due to the
number and complexity of the combined equations, the dynamics of
insulin aggregation were simulated using a Stella II software package
(High Performance Systems, Hanover, NH), with integration by a
Runge-Kutta fourth-order method (Richmond et al., 1990). Details of
model simulation parameters are provided in Chapter 5.
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CHAPTER 4.
RESULTS OF KINETIC STUDIES
4.1 Control Studies
Insulin aggregation rates are affected by a variety of physical
and chemical factors; small changes in temperature, solvent
composition, pH, agitation rates, and contact surface areas, can
significantly affect the overall pattern of destabilization (see Chapter
2). To elucidate the nature of the aggregation reaction, it was
necessary to control aggregation inducing parameters in order to
obtain reproducible kinetic profiles. Care was taken to prepare
buffers, solutions, and samples under identical conditions;
temperature and agitation rates were closely monitored throughout
each study, and to ensure the reliability of experimental results,
most studies were repeated in triplicate.
4.1.1 Reproducibility
Different lots of bovine Zn-insulin were used in this work, and
therefore it was necessary to determine how lot to lot variations
affected the pattern of aggregation. Small differences in Zn2 + content
and specific activities appeared to have little or no effect on insulin
aggregation. As can be seen in Figure 4.1, solutions prepared from
lots 38F-0827 and 128F-0583 (specific activity 25.6 and 24.4 IU/mg,
respectively) exhibited nearly identical aggregation profiles when
agitated in the presence of an air-water interface. Similarly, the
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Figure 4.1: Reproducibility of insulin aggregation rates in the
presence of an air-water interface. Solutions prepared from lots
38F-0827 (0) and 128F-0523 (A) were compared; samples were
agitated at 370C and 250 rpm in 1 ml glass vials.
aggregation patterns of insulin samples prepared from lots 128F-
0583 and 79F-0092 (specific activity 24.4 and 25.7 IU/mg, 0.40 and
0.46 wt% Zn2 +, respectively, Zn2 + content determined by Galbraith
Laboratories) and agitated in the presence of Teflon, were within
experimental error (Figure 4.2). The reproducibility of kinetic
profiles indicated good control over experimental conditions, and
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Figure 4.2: Reproducibility of insulin aggregation rates in the
presence of a Teflon-water interface. Solutions prepared from lots
79F-0092 (U) and 128F-0523 (A) were compared. Samples
containing 10 Teflon spheres were agitated at 370C and 80 rpm. Each
curve was averaged over 2 experiments, with error bars
representing standard deviation from the mean.
suggested that the observed trends were not lot-specific, but
representative of general insulin aggregation behavior.
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4.1.2 Stationary Samples
Previous studies suggested that agitation significantly
contributed to the destabilization of insulin solutions. In the absence
of shaking, no aggregation was observed in samples containing an
air-water (Figure 4.3) or a Teflon-water interface (Figure 4.4 A),
even though the solutions were exposed to elevated temperature
(37 0 C). QELS analysis performed on stationary samples with Teflon
detected only one peak representing native insulin molecules
(monomers, dimers and hexamers), indicating that no destabilizing
interactions were taking place in the absence of agitation (Figure
4.4B).
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Figure 4.3: Effects of agitation on Zn-insulin aggregation in the
presence of an air-water interface. Both stationary samples (0) and
samples agitated at 250 rpm (A) were kept at 370C.
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Figure 4.4: Effects of agitation on Zn-insulin aggregation in the
presence of Teflon. Both stationary samples (0) and samples
agitated at 80 rpm (I) contained 10 Teflon spheres and were kept at
37 0C. (A) Concentration profiles of Zn-insulin aggregation; (B) results
of QELS analysis.
70
I r0000[00 0 0000O 0 0
U
a
U
U
U
I A[]
[]
[]s
v F v -
4.1.3 Comparison of HPLC and UV Analyses
In the initial kinetic studies with an air-water interface, a small
volutne of insulin solution was used per sample (0.75 ml), and the
concentration of non-aggregated protein was determined using the
HPLC analysis, which required only 25 p.l per injection. Although
aggregated solutions were injected without prior filtration, the fully
aggregated, micron-size species never reached the column, as they
could not pass through the 2 p m frit at the inlet. The large
aggregates were not broken down during the analysis: supernatants
of centrifuged samples gave results identical to aggregated samples
which were injected directly onto the column. More than 97% of
injected insulin was recovered, making HPLC analysis a quantitative
and reproducible technique for measuring protein concentrations.
It was hoped that in addition to measuring insulin
concentrations, the HPLC analysis would detect the formation of high
molecular weight intermediate species (less than 1 micron in size),
and provide information about changes in insulin's self-association
equilibrium. At protein concentrations used in these studies, almost
90% of insulin molecules were expected to be in the hexameric form
(Milthorpe et al., 1977). QELS measurements indicated that insulin's
effective diameter in stock solutions was 5 nm (Figure 4.5), which
confirmed the hexamer's presence and predominance. Yet, despite
the mild conditions used with the HPLC analysis, dilution effects and
column-packing interactions disrupted the formation of dimers and
hexamers, and only one peak -- that of monomeric insulin -- was
observed throughout the experiment. No intermediate species were
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Figure 4.5: Results of QELS analysis on non-aggregated (freshly
prepared stock) Zn-insulin solutions. Relative scattering intensity (%
of total) is plotted versus the diameter of the particle responsible for
the scattering. The size distribution histogram was generated using
the program CONTIN.
observed, most likely because they were present in concentrations
below the detection limits of the HPLC analysis. Thus, the only
information provided by size-exclusion chromatography was the
concentration of non-aggregated insulin remaining in solution.
The HPLC analysis proved to be a quantitative and
reproducible method for measuring insulin concentrations; at the
same time, it was slow (requiring -20 minutes for analysis of each
sample), labor intensive (mobile-phase preparation, column cleaning
and equilibration, common switch-overs between aqueous and
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I
organic conditions required by other users of the system), and less
than reliable (mechanical problems with pumps, UV detector and
automated injector). For these reasons, an alternative technique was
evaluated.
The rapidity and non-invasiveness of UV spectrophotometry
made it an attractive alternative to HPLC analysis. The main
difference between the two techniques was that the HPLC analysis
measured the UV absorbance of a monodisperse solution of insulin
monomers, while UV spectrophotometry measured the absorbance of
a polydisperse solution. For unperturbed insulin solutions, both
techniques appeared to work well, generating linear calibration
curves (goodness of fit parameter R2 - 0.984 and 1.000 for HPLC and
UV spectrophotometry, respectively). However, absorbance
measurements in aggregating solutions were complicated by the
formation of intermediate species (the micron-size aggregates were
filtered out), whose presence was expected to interfere with the
analysis. To determine the extent of such interference, UV
absorbance measurements at 280 nm were used to monitor the
concentrations of aggregating insulin solutions, and the results
compared with HPLC analysis performed on the same samples
(Figure 4.6). Fortunately, the concentration of intermediates was so
small as to make the contribution to total absorbance measurements
negligible, making UV spectroscopy an excellent replacement for the
HPLC analysis.
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Figure 4.6: Comparison of UV (0) and HPLC (0) analyses used to
determine the concentration of non-aggregated Zn-insulin in samples
agitated at 80 rpm and 370 C, in the presence of 10 Teflon spheres.
4.1.4 Adsorption to Glass and Teflon
Insulin's interactions with solid surfaces were expected to play
an important role in the aggregation reaction. Since insulin is known
to bind to glass and other materials (Cuatrecasas and Hollenberg,
1975; Sefton and Antonacci, 1984), it was of interest to determine
how much protein was lost due to aggregation, and how much
adsorbed unto container surfaces. The results of adsorption studies
(described in section 3.3.6) indicated that most of the protein ended
up in the aggregated material. On average, 4.4% of initially dissolved
74
*0
D 13
Bile
I
insulin adsorbed to 10 Teflon spheres, less than 0.1% adsorbed onto
glass walls of the sample container, and the remaining 95.5% were
found in the precipitated pellet (Table 4.1).
Table 4.1: Extent of adsorption to glass and Teflon in aggregated
insulin samples (initial concentration 0.6 mg/ml). Results of UV
measurements @ 280 nm on insulin aggregates redissolved in urea¶.
Sample Aggregated Adsorbed Adsorbed Total
Number Material* to Teflon*t to glass*t Absorbancel
0.786
0.775
0.775
0.760
0.782
0.761
0.034
0.030
0.045
0.032
0.037
0.040
0.002
0.002
0.003
0.002
0.003
0.002
0.822
0.807
0.823
0.794
0.822
0.803
Average 0.773 0.036 0.002 0.812
1 The concentration of non-aggregated insulin remaining in solution
was negligible (less than 1 wt%).
* Absorbance units (±.003). Results are reported in absorbance units
rather than weight percent because of the difference in absorbance
of native and aggregated insulin in urea.
t Corrected for dilution effects (i.e., 2/5 and 1/5 of measured
absorbance for Teflon and glass, respectively).
* Absorbance of 0.6 mg/ml native insulin in 8 M urea was 0.609.
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4.1.5 Nature of Aggregate Interactions
To determine the nature of protein-protein interactions
involved in aggregate formation, an HPLC analysis was done on
aggregates redissolved in 8 M urea. Only one peak was observed,
indicating the presence of only one species, which was equivalent in
size to the insulin monomer. The chromatogram was
indistinguishable from that of freshly prepared insulin solution in
PBS. This indicated that no fragmentation of insulin occurred during
aggregation and that the aggregates were held together through non-
covalent (probably hydrophobic) interactions, as was suggested
previously (Lougheed et al., 1983; Brange et al., 1987). It is
interesting to note, however, that when the concentration of
redissolved insulin was determined by UV spectrophotometry, the
absorbance measurements were approximately 33% higher than the
absorbance of native insulin in 8 M urea (Table 4.1). This suggested
that a conformational change took place during aggregation, leading
to the formation of a partially denatured or scrambled structure
when insulin aggregates dissociated in a denaturing reagent. The
increased absorbance could probably be attributed to the exposure of
tyrosine groups, which were shielded from the solvent in the native
structure.
4.1.6 Comparison of Filter Performance
The QELS analysis was extremely sensitive to dust content in
insulin samples, making it essential to remove the fully aggregated
species prior to light scattering measurements. These micron-sized
agglomerates interfered with the UV analysis as well, and filtration
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was necessary for accurate determination of insulin concentrations.
Filtration through polyhydroxypropylacrylate grafted polyvinylidene
difluoride (poly-HPA-PVDF, Millex GV) and polyester-backed
cellulosic (Millex PF) membranes was expected to have little or no
effect on insulin's conformation and self-association (Truskey et al.,
1987), but it was important to determine how much protein was
retained by the filters.
For QELS analysis, the removal of large agglomerates (greater
,han 800 nm) was required, so 0.800 gpm Millex-PF filters were
used. They removed the fully aggregated particles, leaving the
intermediate species unperturbed and available for light scattering
analysis. When the concentration of intermediate species was high,
UV absorbance measurements gave anomalously high readings,
making it necessary to remove the intermediates with 0.200 pm
Millex-GV filters (this happened very rarely). Very little material
was lost: on average, the 0.200 p.m and 0.800 gpm filters retained 2.7
and 1.3 wt% of dissolved protein, respectively. The amount of
adsorbed insulin could be reduced even more by pre-wetting the
filters with fresh (non-aggregated) insulin solutions.
4.2 Air-Water Interface
The initial studies with an air-water interface concentrated on
identifying general patterns in the aggregation reaction. These
experiments were done before the light-scattering equipment was
available, so only time-dependent concentration profiles were
obtained. The studies provided important qualitative information
about the role of various parameters affecting insulin aggregation
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rates; they were also used to evaluate the reliability of the
experimental system, and to identify problems which interfered with
adequate characterization of destabilization pathways.
4.2.1 Concentration Dependence Studies
The first series of experiments focused on the effects of insulin
concentration on overall aggregation rates. It soon became apparent
that at higher insulin concentrations, more time was required for
aggregation. Subsequent studies were done to obtain detailed kinetic
profiles; the results are shown in Figure 4.8. At each concentration, a
characteristic curve shape was observed: initially, there was a
period of stability (a flat portion during which no aggregation was
detected); it was followed by a sloping portion, which indicated
insulin depletion resulting from aggregation. Comparison of solution
half-lives (tl/2 defined as the time when insulin concentration were
reduced to 50% of the original concentration) revealed greater
stability (longer half-lives) at higher concentrations. For initial
concentrations of 0.6, 0.3 and 0.1 mg/ml, the tl/2 values were 12, 6
and 3 hours, respectively (Figure 4.8).
This positive correlation between stability and concentration
was somewhat anomalous. In general, protein aggregation processes
appear to be kinetically cont olled, and rates of aggregation tend to
be proportional to protein concentrations (Zettlmeissl et al., 1979).
For example, thermally induced aggregation has been reported to
increase with protein concentration (Klibanov, 1983), and dilution
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Figure 4.7: Concentration dependence of Zn-insulin aggregation
rates in the presence of an air-water interface. Samples with initial
concentrations of 0.6 mg/ml (A), 0.3 mg/ml (0), and 0.1 mg/ml (U)
were agitated at 250 rpm and 370 C.
was shown to enhance stability. The opposite was observed in Zn-
insulin solutions, where the propensity to aggregate was lower at
higher protein concentrations. Similar results have been reported
previously (Lougheed et al., 1983; Brange and Havelund, 1983); yet,
no adequate explanation has been proposed for this anomalous
behavior. A successful kinetic model of insulin aggregation would
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have to explain and predict both the concentration dependence and
the characteristic curve shape.
4.2.2 Role of Agitation
The next set of experiments examined the effects of agitation
rates on Zn-insulin aggregation (Figure 4.8). In the absence of
agitation, no aggregation was observed for more than 2 weeks, while
rapid agitation (250 rpm) led to complete aggregation in only 18
0.60
0.30
0.00
186 12
Days
Figure 4.8: Effects of agitation rate on
Samples (initial concentration of 0.6 mg/ml,
250 rpm (0), 120 rpm (A) and 0 rpm (I) in
water interface.
Zn-insulin aggregation.
370 C) were shaken at
the presence of an air-
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hours. When the agitation rate was reduced to 120 rpm, the
induction period (flat portion of the curve) increased from 4 hours to
almost 6 days, and the solutions aggregated fully in 6.5 days.
However, a direct correlation between increases in agitation and
aggregation rates could not be drawn, since the air-water interface
also increased with agitation (because of foaming and bubble
formation). Thus, while the results of these experiments pointed to
the importance of agitation, the difficulties associated with
decoupling the contributions of improved mixing and a larger air-
water interface prevented the formulation of a quantitative
relationship between agitation and aggregation. To further
investigate the role of agitation, it was necessary to vary agitation
rates without changing the size of the hydrophobic interface.
4.2.3 Role of Air-Water Interface
The importance of both mixing rates and air-water interfaces
became evident once again when insulin samples with and without
headspace were agitated at 250 rpm (Figure 4.9). Samples with an
air-water interface aggregated in less than a day, while those
without any headspace remained stable for over a week. In the
samples lacking headspace, mixing (as well as the air-water
interface) was eliminated, and mass transfer inside the vials was
limited by diffusion. As in the no agitation case described above, it
was difficult to distinguish between the effects of mixing and
hydrophobic interfaces on insulin destabilization, although it became
clear that both parameters were necessary for rapid and
reproducible aggregation.
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Figure 4.9: Effects of air-water interface on Zn-insulin aggregation
rates. Samples (initial concentration of 0.6 mg/ml) with (A) and
without (O) an air-water interface were agitated at 250 rpm and
370C.
4.3 Teflon-Water Interface
The experiments with an air-water interface provided valuable
insights about the concentration dependence of insulin aggregation.
However, it was very difficult to characterize and quantify the air-
water interface, and nearly impossiblc to independently evaluate the
contributions of the hydrophobic interface and mixing rates to the
overall pattern of aggregation. Replacement of headspace with
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Teflon spheres provided the necessary control of agitation rates and
hydrophobic surface areas, and allowed for a quantitative analysis of
surface interactions and mass transfer. In addition to monitoring
concentration changes, light scattering measurements were done to
determine the particle size distributions in the destabilized samples.
The combination of these two analytical methods provided a more
complete picture of the aggregation reaction.
4.3.1 Concentration Dependence
Insulin aggregation in the presence of Teflon spheres was very
similar to the behavior observed with an air-water interface. As
insulin concentrations increased, so did solution stability, with tl/2
values increasing from 16 to 30 hours for initial concentrations of 0.2
and 0.6 mg/ml, respectively (Figure 4.10).
The characteristic curve shape -- an induction period followed
by a sloping section -- was also observed, and was in good
qualitative agreement with the air-water interface results. This
suggested that the use of Teflon spheres did no introduce any
artificial effects, and that the experimental set-up indeed mimicked
the destabilizing conditions present in many drug-delivery
environments.
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Figure 4.10: Concentration dependence of Zn-insulin aggregation
rates in the presence of a Teflon-water interface. Samples containing
5 Teflon spheres were agitated at 80 rpm and 37 0 C. Initial
concentrations were 0.6 mg/mi (A), 0.4 mg/ml (0), and 0.2 mg/ml
(0). Each curve is the average of 3 experiments, with error bars
representing standard deviation from the mean.
4.3.2 Effects of Surface Area and Agitation Rates
In the presence of Teflon spheres, it became possible to vary
the size of the hydrophobic surface without changing the agitation
rates. Figure 4.11 illustrates the effects of an increased hydrophobic
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interface on insulin aggregation. When the number of Teflon spheres
was doubled from 5 to 10 per sample, the flat portion of the profile
(the induction period) became shorter, and the slope of the curve
became steeper. Similar results were obtained when the agitation
rate was doubled (Figure 4.12). These observations pointed to the
importance of insulin interactions with the hydrophobic interface
and to the role of mass transfer and/or shear denaturation in the
aggregation process.
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Figure 4.11: Effects of Teflon surface area on Zn-insulin
aggregation rates. Samples (initial concentration of 0.6 mg/ml) were
agitated at 80 rpm and 37 0 C, with 5 (A) and 10 (0) Teflon spheres.
Each curve is the average of 3 independent experiments, with error
bars representing standard deviation from the mean.
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Figure 4.12: Effects of agitation rate on Zn-insulin aggregation.
Samples (initial concentration of 0.6 mg/ml) containing 10 Teflon
spheres were agitated at 80 (0) and 160 (0) rpm. Each curve is the
average of 3 independent experiments, with error bars representing
standard deviation from the mean.
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4.3.3 Results of QELS Analysis
The overall shape of the curves suggested that aggregation was
analogous to a phase transition, such as the formation of ice, protein
precipitation, or crystallization. In each case, the first step is
nucleation -- formation of stable inte;lnediate species which
facilitate the growth of crystals or precipitates (Kam et al, 1978).
QELS analysis revealed the presence of such stable intermediates in
aggregating insulin solutions. Typical experimental results are
presented in Figure 4.13.
Initially, only native insulin molecules were present in solution,
as reflected by the peak at 5 nm (Figure 4.13 A). Due to the small
size of the insulin monomer and the small differences in the
hydrodynamic diameters of the monomers, dimers, and hexamers, it
was difficult to distinguish among these species.
(The scattering intensity is proportional to the particle
diameter raised to the sixth power. At Zn-insulin concentrations
used in these experiments, the monomer made up only 4% by weight
of particles in solution. Therefore, the monomer's scattering
intensity was only 0.1% of hexamer's scattering, while the dimer was
responsible for approximately 0.3% of the signal -- contributions too
small for meaningful resolution of particle sizes (see appendix A for
details). The algorithm CONTIN used to generate the depicted
histograms sought continuous distributions rather than discrete
spikes; while this reduced the problem of spurious peaks, it also
smoothed out the particle size distribution (Brookhaven, 1986),
making it nearly impossible to separate out the populations involved
in Zn-insulin's dynamic self-association equilibrium.)
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Figure 4.13: Representative results of QELS analysis of insulin
solutions (0.6 mg/ml) agitated in the presence of 10 Teflon spheres.
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Just in an hour of agitation in the presence of Teflon, a second peak
appeared (Figure 4.13 B), corresponding to particles of approximately
150 nm in diameter, which made up less than 0.01% (w/w) of total
protein in solution. This bi-modal distribution was observed
throughout the experiment: even in an almost fully aggregated
solution (following 23 hours of agitation), a native peak at
approximately 5 nm and an intermediate peak at 170±20 nm were
present (Figure 4.13 C). Thus, there were three distinct types of
species in solutions of aggregating insulin: the native molecules
(monomers, dimers, hexamers), represented by the peak at 5 nm; the
fully aggregated micron-size particles (larger than 0.8 pm), filtered
out prior to analysis; and the stable intermediates rep:esented by
the peak at 170±20 nm. It is important to note that the intermediate
species appeared before aggregation could be detected by other
means (such as changes in concentration or visible turbidity). This
suggested that the initial stages of aggregation involved relatively
few destabilized molecules, and that the intermediate species
facilitated subsequent aggregation.
It is necessary to emphasize that QELS is a low resolution
technique. For monodisperse samples, it can be used to determine
particle sizes with ±3% accuracy, but for polydisperse solutions, the
certainty in the measured diffusion coefficients is much lower
(Brookhaven, 1986). The analysis of polydisperse samples had to
assume a particular form (bi-modal, tri-modal, etc.), but choosing an
appropriate form using the best statistical fit is not recommended,
because function g(,T) is an ill-conditioned equation (Brookhaven,
1986). Furthermore, the analysis assumed that all particles were
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spherical. While this assumption held up well for the insulin
hexamer (a globular protein), there was no evidence about the shape
of the intermediate species. It is possible that the intermediate's
shape would have been better described as a rod or a random coil.
This uncertainty also reduced the accuracy of particle size
measurements. Given these complications, the intermediate's
diameter could not be determined with better than ±10% accuracy,
and the weight distribution of insulin species could be only roughly
estimated. Despite these limitations, the insights provided by QELS
analysis were instrumental in the formulation of the kinetic scheme.
4.3.4 Na-insulin Aggregation
In the absence of Zn2 +, insulin's self-association was disrupted;
fewer dimers assembled into hexamers, and a larger proportion of
molecules remained monomeric. To examine the effects of increased
monomer concentrations on insulin aggregation rates, the
destabilization of bovine Na-insulin was examined.
Figure 4.14 illustrates that solutions of Na-insulin aggregated
faster than equimolar solutions of Zn-insulin; the induction period
was reduced from 8 to less than 1 hour, and the slope of the curved
portion became steeper. Lower hexamer content in Na-insulin
solutions was evident from QELS analysis (Figure 4.15 A): the peak
representing native insulin species shifted from 5 to 4 nm, indicating
the predominance of monomers and dimers over hexamers. While
hexamer formation was reduced, it was not eliminated entirely.
Because of the strong correlation between particle size and scattering
intensity, the presence of even a minute amount of hexamers would
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Figure 4.14: Concentration profiles for Na- (0) and Zn- (A) insulin
solutions, aggregating in the presence of 10 Teflon spheres at 80 rpm
and 370 C. Results were averaged over three experiments, with error
bars representing standard deviation from the mean.
significantly affect the QELS results. This was why only a small
change was observed between the effective diameters of scattering
species in Zn- and Na-insulin solutions. In addition to the native
peak at 4 nm, stable intermediate species (150::20 nm) were
detected in aggregating Na-insulin solutions (Figure 4.15 B); this was
consistent with insulin aggregation behavior observed in Zn-insulin
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Figure 4.15: Results of QELS analysis on Na-insulin solutions.
Samples (initial concentration 0.6 mg/ml) were analyzed (A) at time
0, and (B) after 2.4 hours of agitation at 80 rpm and 370C in the
presence of 10 Teflon spheres. Relative scattering intensities (% of
total) are plotted versus the diameter of the particle responsible for
the scattering. These size distribution histograms were generated
using the program CONTIN.
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solutions. The observed decreases in solution stability of Zn-free
insulin were in good agreement with reports in the literature which
suggested that aggregation was initiated by insulin monomers
(Brange et al., 1987).
4.3.5 Temperature Dependence
The detrimental effects of elevated temperature on protein
stability are well known (Ahern and Klibanov, 1988). It was of
interest to determine how temperature changes influenced insulin
aggregation rates. As can be seen in Figure 4.16, solution stability
declined dramatically as temperature increased from 4 to 47 0C. No
aggregation was observed and no intermediate species were detected
in insulin solutions agitated at 40C even after one week. Insulin
solutions aggregated at the other examined temperatures; the half-
life values were 3, 6 and 72 hours at 47, 37 and 27 0C, respectively.
QELS analysis detected stable intermediate species (170±20 nm) in
all destabilized solutions.
Temperature changes probably affected insulin's self-
association equilibrium and the rates of many steps involved in the
aggregation reaction, making it difficult to attribute the accelerated
destabilization to any one set of interactions. Rather, it suggested
that as the temperature was raised, the combination of reduced self-
association, increased monomer denaturation and faster diffusion, led
to more rapid aggregation.
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Figure 4.16: Temperature dependence of Zn-insulin aggregation
rates (samples agitated at 160 rpm in the presence of 10 Teflon
spheres): (0) 470C, (0) 37 0C, (0) 270 C and (0) 40C.
4.4 Other Hydrophobic Interfaces
Insulin aggregation in the presence of air-water and Teflon-
water interfaces suggested that initial destabilization was mediated
by insulin's interactions with hydrophobic surfaces. It was
hypothesized that the monomer's reversible adsorption to Teflon
resulted in conformational changes (exposure to solutions of internal
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hydrophobic moieties) conducive to aggregation; the association of
destabilized monomers removed exposed hydrophobic groups from
the aqueous environment before the native conformation could be
restored. To verify that destabilization was not specific to air or
Teflon, but was a result of interactions between any hydrophobic
surface and insulin, aggregation in the presence of polypropylene,
siliconized glass, and unmodified glass beads was examined.
4.4.1 Polypropylene
Aggregation was indeed observed in solutions containing
hydrophobic materials. Solutions agitated in the presence of
polypropylene spheres aggregated completely in 3 days (Figure
4.17). The characteristic biphasic shape was observed, although the
induction period increased to 16 hours (compared to 4 hours for
samples with Teflon spheres), and the slope of the curved section
became less steep. Stable intermediate species were also detected in
the presence of polypropylene, and the results were in excellent
qualitative agreement with insulin aggregation in the presence of
Teflon (Figure 4.18). The relatively slow aggregation with
polypropylene spheres was attributed to the fact that
polypropylene's low density (p=0.9 g/ml) reduced the amount of
agitation. While Teflon spheres (p= 2.16 g/ml) moved up and down
the sample vials as the shaker platform rotated, polypropylene
spheres floated at t'e top of the samples and hardly moved at all.
Slower fluid motion in insulin samples with polypropylene reduced
the extent of mixing, which meant that fewer interfacial interactions
occurred in a given time period. As no destabilization was observed
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Figure 4.17: Effect of surface hydrophobicity on Zn-insulin
aggregation. Samples were agitated at 160 rpm and 370C in the
presence of 10 Teflon (Q) and 10 polypropylene (0) spheres.
in stationary samples (see 4.1.2), it was expected that reduced
agitation would lead to slower aggregation. Consequently, even
though the surface hydrophobicity of polypropylene was similar to
that of Teflon (critical surface tension of 34 and 22 dyne/cm for
polypropylene and Teflon, respectively, (Shafrin, 1975)), reduced
mass transfer and/or shear denaturation at the polypropylene
surface led to slower destabilization and aggregation (see 5.3.5).
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Figure 4.18: QELS analysis of Zn-insulin aggregation upon shaking.
relative scattering intensities (% of total) are plotted versus the
diameter of the particle responsible for the scattering. These size
distribution histograms were generated using the program CONTIN.
Results shown are for ti/2 of Zn-insulin solutions agitated at 160 rpm
and 370C, in contact with (A) 10 Teflon spheres (5 hours) and (B) 10
polypropylene spheres (42 hours).
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4.4.2 Siliconized Glass
In the presence of siliconized glass beads, the induction period
was increased to 12 hours, and insulin solutions aggregated fully in
less than 2 days (Figure 4.19); formation of stable intermediate
species was also detected by QELS (Figure 4.20 A). No aggregation
was observed for more than a week in solutions containing relatively
hydrophilic, unmodified glass beads (Figure 4.19). As can be seen in
Figure 4.20 B, a small amount of the intermediate species was also
detected in samples with unmodified glass. This was probably due to
the fact that the surface of glass beads was not perfectly hydrophilic,
and that shear effects could have contributed to the formation of
intermediate species.
In the case of siliconized glass beads, the mixing rates (and
thus mass transfer and shear effects) were similar to those observed
with unmodified glass beads, while the surface was much more
hydrophobic. It was difficult to estimate the extent and
reproducibility of surface modifications; the large standard deviation
from the mean in the aggregation profile suggested that hydrophobic
functional groups were not uniformly distributed on the bead
surface. Although uncertainty about the actual aggregation profile
prevented mathematical modeling of insulin's interactions with
siliconized glass, the most important observation was that insulin
aggregated fully within 2 days in the presence of this modified
hydrophobic surface, while no aggregation was observed in the
presence of the much more hydrophilic glass beads.
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Figure 4.19: Effect of surface hydrophobicity on Zn-insulin
aggregation. Samples were agitated at 160 rpm and 37 0 C in the
presence of hydrophobic siliconized glass (A) and hydrophilic
unmodified glass spheres (O). Results were averaged over 2
experiments, with error bars representing standard deviation from
the mean.
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Figure 4.20: QELS analysis of Zn-insulin aggregation upon shaking.
Relative scattering intensities (% of total) are plotted versus the
diameter of the particle responsible for the scattering. These size
distribution histograms were generated using the program CONTIN.
Results shown are for tl/2 of Zn-insulin solutions agitated at 160 rpm
and 370 C, in contact with (A) 11 siliconized glass spheres (24 hours)
and (B) 11 unmodified glass spheres (6 days).
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4.5 Insulin Aggregation in Organic Solvents
Insulin aggregation was assumed to be analogous to other
protein systems, in which destabilization was initiated by
denaturation, or partial conformational changes in native structure:
Since configurational changes occur in protein
denaturation (with frequent liberation of functional
groups previously buried in the interior of the molecule),
it is to be expected that the interaction energy between
the molecules of any protein varies when this protein
undergoes denaturation. As a consequence of such a
variation of interaction energy, the state of dispersion of
the molecules in solution may change. For instance,
association or polymerization, and more generally
aggregation or even coagulation may occur. (Joly, 1965).
This generally accepted mechanism which identified hydrophobic
interactions as the driving force for protein aggregation in aqueous
solutions (Volkin and Klibanov, 1990), appeared to be consistent with
the formation of non-covalent insulin aggregates. Furthermore, the
experiments with solid-water and air-water interfaces suggested
that insulin's interactions with hydrophobic surfaces produced
partially denatured species (Figure 4.21), which minimized their
surface energy by interacting with each other in order to shield
exposed hydrophobic groups from unfavorable contacts with the
aqueous environment.
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In an organic solvent, insulin's native conformation would be
lost, but exposure of hydrophobic moieties would no longer be a
thermodynamic liability. Consequently, conformational changes at an
air-liquid interface should not lead to aggregation, since there would
be no incentive to minimize contacts between exposed hydrophobic
groups and the solvent. To verify this reasoning, samples of insulin
in various protein-dissolving (Chang and Klibanov, 1992) organic
solvents (formamide, DMSO and ethylene glycol) were subjected to
the same physical perturbations which led to rapid aggregation in
aqueous solutions. As seen in Figure 4.22, no aggregation was
observed during the 7-day experiment. This result was revealing
from a mechanistic standpoint, since it lent additional support to the
proposed model of insulin destabilization and aggregation (see
chapter 5). Together with the fact that insulin aggregates were held
together by non-covalent interactions (which could be disrupted by
overnight incubation in 8 M urea, as discussed in section 4.1.5),
insulin's stability in organic solvents supported the idea that in
aqueous environments, aggregation was initiated by exposure of, and
interactions between, hydrophobic groups.
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Figure 4.22: Aggregation of Zn-insulin solutions agitated at 100
rpm and 370C in the presence of an air-liquid interface. Insulin in
PBS (*), ethylene glycol (U), formamide (0), and DMSO (A). Insulin's
absorbance at 280 nm was determined by subtracting the
absorbance of the solvent (0.010, 0.042, 0.096 and 0.260 for PBS,
ethylene glycol, formamide and DMSO, respectively) from the total
absorbance. The increased absorbance in formamide was probably
due to insulin's slow, time-dependent conformational transition in
this organic solvent.
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CHAPTER 5.
MODEL FORMULATION AND RESULTS OF COMPUTER
SIMULATIONS
5.1 Formulation of Aggregation Scheme
The mechanism of insulin destabilization and aggregation in
aqueous solutions remains obscure. It has been suggested that the
process is mediated by adsorption at hydrophobic interfaces (air-
water and water-pump materials) (Thurow and Geisen, 1984), and
that the initial step is the formation of small intermediate aggregites
which serve as precursors to large precipitates (Dathe et al., 19'0).
These elements alone, however, fail to describe the insulin
aggregation behavior: a successful kinetic scheme has to predict both
the bi-phasic nature of this reaction's time-course and the increased
insulin stability at higher concentrations (which in the past has been
attributed only to the concentration dependent self-association
equilibrium).
To identify the insulin species most susceptible to
destabilization, conformational stability of different association states
was considered. In solutions, insulin monomers are in equilibrium
with the more stable dimers and hexamers (Jeffrey, 1974). The
insulin hexamer has a compact globular structure with a largely
polar surface (Blundell et al., 1972); it has been shown that
increasing hexamer concentration by addition of phenol (Derewenda
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et al., 1989) or Zn2+ (Brange et al., 1986) enhanced solution stability.
The hexamer's conformational stability makes it an unlikely
candidate for denaturation at a hydrophobic surface. Partial
unfolding of the insulin dimer at hydrophobic surfaces can be
discounted for similar reasons: one of the monomer's two
hydrophobic regions is involved in dimer formation (Blundell et al.,
1972), and these intermolecular interactions greatly stabilize its
tertiary structure. Thus, of the three insulin species present in
solution, the monomer is the most likely to undergo conformational
changes when it interacts with hydrophobic surfaces. This is
consistent with the increased aggregation rates observed in Na-
insulin solutions, in which higher monomer concentrations were
present (see 4.3.4). In solutions where insulin's self-association had
been eliminated altogether (Zn-free insulin in 0.1 M TRIS and 60%
ethanol, pH 7), aggregation rates increased with increasing insulin
concentrations (Brange et al., 1987), implying that it was the
monomer which initiated the formation of insoluble agglomerates.
Insulin denaturation at hydrophobic interfaces (solid-water
and air-water) has been reported (Feingold et al., 1984; Hansen et al.,
1987), and the extent of insulin adsorption to glass and Teflon has
been determined (Sefton and Antonacci, 1984), making possible a
semi-quantitative characterization of insulin's interactions with these
surfaces. Due to the difficulties associated with measuring and
controlling the air-water interface, mathematical modeling was
restricted to insulin aggregation in the presence of solid surfaces.
The results of kinetic studies done with Teflon spheres were
particularly well suited for computer simulations, as it was possible
106
to estimate the sizes of hydrophobic surface areas, extent of insulin
adsorption, and changes in mass transfer resulting from variations in
agitation rates. A model explaining insulin destabilization at solid
hydrophobic, surfaces could then be used to elucidate insulin
aggregation in the presence of air-water interfaces, as the two
phenomena were qualitatively similar.
Based on the overall kinetics of insulin aggregation, the
formation of stable intermediate species, and the importance of
interfacial interactions, a mechanism of insulin destabilization and
aggregation in the presence of solid hydrophobic surfaces was
formulated. The proposed reaction pathways are depicted
schematically. in Figure 5.1. As no aggregation was observed in the
absence of hydrophobic interfaces (and in the presence of
hydrophilic glass beads), insulin's interactions with glass were
assumed to have no detrimental effects.
The unfavorable conformational changes leading to aggregation
were assumed to be mediated by insulin's interactions with
hydrophobic surfaces. It was hypothesized that dimers and
hexamers reversibly adsorbed to Teflon without undergoing
significant conformational changes. However, the less stable
monomeric species became partially unfolded upon adsorption to
Teflon. The unfolded species either snapped back to the native
conformation (the most likely event), or combined with other
unfolded species, initiating nucleation (Kam et al, 1978) -- the
formation of intermediate aggregates of approximately 170 nm in
diameter. The smaller intermediates (U2 , U3, etc.) were short-lived
transients: they continuously combined and fell apart, and were able
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Figure 5.1: Schematic representation of the proposed mechanism of
insulin aggregation in the presence of a Teflon-water interface.
Species: native , unfolded , aggregates .
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to interact only with other unfolded species. Once a critical size was
reached, the intermediates had enough surface area for stability, and
could start trapping the native molecules. The slow formation of the
170+20 nm stable intermediates explained the lag time: no
significant aggregation was observed until a population of nucleating
species was established (Sluzky et al., 1991).
The increased stability at higher concentrations (when a larger
proportion of insulin was oligomeric) was attributed to the
occupation of the Teflon surface by dimers and hexamers, which
reduced the surface available to unfold insulin monomers. As insulin
concentration increased, so did the monomer concentration. In the
absence of dimer and hexamer adsorption to Teflon, higher insulin
concentrations would lead to more rapid aggregation, as the rate of
denaturation (which initiated the process of destablilization)
depended on the concentration of both monomers and interfacial
sites (Table 5.1). In order to reduce the driving force for aggregation
at higher concentrations, the number of interfacial sites causing
monomer denaturation had to be reduced. One way to accomplish
this, given a fixed surface area, was to allow the more stable species
to occupy interfacial sites without undergoing conformational
changes.
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5.2 Mathematical Formulation of Reaction Kinetics
The interactions in the proposed aggregation model were as
follows:
Kdim Khex
6N <======> 3N2 < -====> N6
K2ads
N2 + I <======> N2I
K6ads
N6 + I <======> N6I
k unf
N+I .-====> U+I
k ref
U ======> N
k U-form
U + U <======> U2
k U-diss
U2 + U <=-====>U3
Un-I + U <======> Un etc.
{1}
{2}
{3}
{4a}
{4b}
{5}
k agg
Un + (N or N2) ======> Aggregates
Notation:
N = native insulin monomer (concentration, M)
N2  = native insulin dimer (concentration, M)
N6  = native insulin hexamer (concentration, M)
U = partially denatured insulin monomer (concentration, M)
U2 = transient intermediate species (concentration, M)
Un = stable intermediate species (-170±20 nm) (concentration, M)
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{6}
I = interfacial sites (concentration, sites/ml)
N2I = dimer adsorbed on hydrophobic surface (concentration, M)
N6I = hexamer adsorbed on hydrophobic surface (concentration, M)
Step 1 represented insulin's self-association equilibrium, while
steps 2 and 3 were used to describe the adsorption of dimers and
hexamers to Teflon. Step 4 in the reaction scheme represented
monomer denaturation induced by contacts with the hydrophobic
surface; this was assumed to be a pseudo-equilibrium process (since
intramolecular changed occurred on a much shorter time-scale than
bimolecular interactions (Creighton, 1984)), in which
K denat=kunf/kref. Step 5 (the formation of stable intermediate
species) was modelled as a stepwise polymerization with equal
probability of subsequent addition. To simplify the computations
without changing the qualitative features of the kinetic scheme, the
number of steps needed to reach a critical size was limited to 9 (with
n= 10). As a result, the numbers used in the simulations were
pseudo-rate constants.
In step 6, the stable intermediates reacted with native insulin
monomers and dimers, to form large, insoluble agglomerates. The
hexamer did not participate in step 6, since interactions between
stable intermediates and native species were assumed to be
hydrophobic. While insulin monomers and dimers had large
hydrophobic areas which could easily interact with the
intermediates, the hexamer's hydrophilic surface (Blundell et al.
1972) made such associations much less likely (J. Brange, personal
communication).
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Only qualitative predictions could be expected from this model
since the actual kinetic rate constants (for formation of aggregates
and intermediates) could not be determined independently; yet, the
computer simulations proved to be very helpful in elucidating the
nature of aggregation and stabilization mechanisms. Most of the
parameters used in the model were estim'. red from the literature;
the results are summarized in Table 5.2, and details about how these
parameters were determined are provided in sections 5.2.1-5.2.4.
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Table 5.2: Thermodynamic and kinetic parameters used to model
insulin aggregation in the presence of solid hydrophobic surfaces.
Parameter Value Reference
Kdim
Khex (Zn-free)
Khex (Zn-insulin)
6.9x10 4 M-l* (Mark and Jeffrey, 1990)
3.2x10 8 M-2 * (Mark and Jeffrey, 1990)
1.3x10 13 M- 2* (Milthorpe et al., 1977)
(1.2-2.5)x10- 16 ml/sitet
(4.8-9.9)x10 - 17 ml/sitet
Kdenat (Teflon, 80 rpm)
K denat (polypropylene)
k U-form
k U-diss
k agg
2.0x10- 16 ml/site§
5.5x10 - 17 ml/site
6.0x10 6 M- 1 min- 1
3.0x10 5 min- 1
3.0x105 M-1 min- 1
(Sefton et al, 1984)
(Sefton et al, 1984)
(Brems et al., 1990)
see text
see text
see text
see text
* Extrapolated to our experimental conditions (37 0 C, I = 0.14)
t Calculated assuming K6ads=0. 4 xK2ads. Adsorption coefficients
increased as insulin concentration decreased from 0.10 to 0.017 mM.
§ K denat was estimated to be one order of magnitude greater than
the value reported for bulk solutions; it was then scaled by the
average number of hydrophobic interfacial sites.
ml/site at 160 rpm
Kdenat = 4x10- 1 6
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K2ads
K6ads
5.2.1 Parameters for Self-Association Equilibrium
Insulin's oligomerization has been investigated by numerous
researchers (see 2.1.2), who have determined the equilibrium
constants for dimer and hexamer formation at various temperatures,
pHs, and ionic strengths. The majority of these studies focused on
Zn-free insulin solutions, and the equilibrium constants were
calculated based on a variety of self-association patterns (see Figure
2.2). The dimerization and hexamerization parameters in our model
were extrapolated from the results of (Mark and Jeffrey, 1990),
(Jeffrey et al., 1976) and (Milthorpe et al., 1977), as Table 5.3
illustrates. The values reported for the "Indefinite Isodesmic of
Hexamers" model for Zn-free insulin self-association at pH 7, I 0.05
and 0.1, and 250 C and 37 0 C, (Mark and Jeffrey, 1990) (model 4 in
Figure 2.2) were compared with the numbers reported by (Jeffrey et
al., 1976) for Zn-free insulin at pH 7.0, I 0.2, and 25 0C. The
equilibrium constant for hexamer formation in the presence of Zn
was based on values determined by (Milthorpe et al., 1977), while
dimer formation was assumed to remain unchanged in Zn- and Zn-
free insulin solutions.
5.2.2 Adsorption Coefficients
The coefficients for dimer and hexamer adsorption to Teflon
were calculated from the adsorption isotherms at 370C reported by
(Sefton and Antonacci, 1984). A total Teflon surface area of 1.19 cm 2
was used in Sefton's studies, and results were given in terms of
insulin units (U) adsorbed per 1 cm2 of Teflon at specified bulk
concentrations of Zn-free insulin in a phosphate buffer. The dimer
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was assumed to be responsible for adsorption, as it was the
predominant species in Zn-free solutions. In this work, it was
assumed that the hexamer also adsorbed to Teflon, although not as
readily- as the more hydrophobic dimer. Hexamer's interactions with
Teflon probably resulted in dissociation into dimers, which then
adsorbed to the surface. To reflect the lower affinity of the hexamer
for the hydrophobic surface, its adsorption coefficient was
subsequently assumed to be smaller than that of the dimer.
The surface area occupied by adsorbed dimers was reported to
be 750 A2; the hexamer's surface area was similarly calculated to be
2250 A2. Thus, in Sefton's experiments there were 1.59x10 13 dimer
([IOldim) or 5.29x10 12 hexamer ([IO]hex) sites per ml (based on
available Teflon surface area of 1.19x10 1 6 A2/ml). The average
specific activity of insulin (25 U/mg) was used to calculate the
number of units per individual dimer and hexamer molecule as
follows:
12,000 mg dim 1 mMol 25U 5x10 U/dim 15.1}
1 mMol 6 x 1020 dim 1 mg
36,000 mg hex 1 mMol 25 U
1 mMol 6 x 1020 hex 1 mg 1.5x U/hex 5.2
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The concentration of insulin adsorbed on Teflon ([N]Tef, U/ml)
could then be expressed in terms of bulk concentrations
(molecules/ml) of dimers [N2] and hexamers [N6]:
[N]Tef=K2adsx[N2]x[IO]dimX[U/dim]+K6adsx[N6]x[Io]hexx[U/hex] {5.3}
Equation 5.3 could be simplified by calculating
[I0]dimx[U/dim]= [I0]hexx[U/hex]=7.9x10- 3 (U site/ml molecule)
and expressing K6ads as a function of K2ads:
K6ads=Y x K2ads
{5.4}
{5.5}
The adsorption coefficient for the insulin dimer could then be
calculated from
[N]Tef (U/ml) x 1
7.9x103( U Site ) ([N2]+Yx[N6])(molec/ml)
ml molec
{5.6}
The results presented in Table 5.4 were calculated using
equation 5.6; hexamer adsorption was varied by setting Y to 0, 1 and
0.4 to represent the cases of no hexamer adsorption, equal dimer and
hexamer affinity for the surface, and higher dimer adsorption,
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Table 5.4: Concentration dependence of dimer adsorption
coefficients in Zn-free insulin solutions.
Bulk Surface K2ads (ml/site) x 101 6
Concentration Concentration ---- ------
(mg/ml) (U/ml) x10- 3  Y=0* Y=lt Y=0.4§
0.6 16 1.3 1.1 1.2
0.4 13 1.5 1.3 1.4
0.2 8.7 1.9 1.9 1.9
0.1 5.0 2.5 2.5 2.5
* K2ads calculated assuming no hexamer adsorption.
t K2ads calculated assuming K2ads = K6ads.
§ K2ads calculated assuming K6ads = 0. 4xK2ads.
respectively. It became evident that K2ads remained virtually
unchanged in all three cases, indicating that hexamer adsorption had
little or no effect on the stability of Zn-free insulin solutions. This
was not surprising, as in the absence of Zn2+, hexamers made up a
very small fraction of molecules in solution. The situation would
change dramatically in Zn-insulin solutions, where hexameric species
predominated; the extent of hexamer adsorption significantly
affected the predictions of solution stability, and the observed
concentration dependence could not be modelled successfully in the
absence of hexamer occupation of destabilizing interfacial sites (see
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Appendix B). Consequently, adsorption constants calculated
assuming K6ads = 0. 4 xK2ads were used in computer simulations of
insulin aggregation in the presence of Teflon.
5.2.3 Monomer Denaturation at Hydrophobic Surfaces
To describe conformational changes resulting from insulin
monomer's interactions with hydrophobic surfaces, the equilibrium
constant for unfolding and refolding the absence of destabilizing
interactions was estimated from the literature. Insulin's Gibbs free
energy of unfolding at room temperature (23 0C) was reported to be
4.5+0.5 kcall/mol (Brems et al., 1990). The equilibrium constant of
unfolding (Kunf) could be calculated from the thermodynamic
relationship
Kunf = exp (-AGunf/RT) (Modell and Reid, 1983) {5.7}
Using equation 5.7, the equilibrium constant for unfolding was
determined to be 2x10 -4 .
To include the destabilizing effects of insulin's interactions with
hydrophobic surfaces, Kunf' (the equilibrium constant for unfolding
in the presence of Teflon) was estimated to be one order of
magnitude greater than Kunf in bulk solutions. Kdenat was then
calculated by scaling Kunf' (2x10- 3 ) by the average number of
hydrophobic interfacial sites (order 1013 sites/ml) present in samples
used in kinetic studies with solid hydrophobic surfaces. This order of
magnitude estimate for Kdenat (2x10-16 ml/site) was used to
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describe monomer unfolding resulting from interactions with Teflon
spheres at 370C and 80 rpm.
Kdenat contained information about both mass transfer to the
hydrophobic surface and the rate of unfolding at that solid-water
interface. In subsequent computer simulations, the value of Kdenat
was varied to reflect changes in agitation rates, shear-denaturation
and surface hydrophobicity.
5.2.4 Interfacial Sites' Available for Monomer
Denaturation
The concentration of destabilizing interfacial sites was
determined in the following way. Total available surface area AO
was calculated as (number of spheres)x(sphere's surface area), e.g.
5x(nrxD 2) for five spheres of diameter D. AO was then divided by total
sample volume, 5.1 and 4.4 ml for samples containing 5 and 10
Teflon spheres (0.635 cm OD), respectively. The concentration of
interfacial sites was determined by dividing initial surface area
(A 2/ml) by the size of an individual site, which was assumed to be
2000 A2 (based on hexamer's cross-sectional area .(Blundell et al,
1972), since the hexamer was the predominant insulin species in
solution at these concentrations).
Thus, in samples containing 5 and 10 Teflon spheres, there
were 6.3x10 12 and 1.4x10 13 sites/ml, respectively, at the beginning
of each experiment. Adsorbed dimers and hexamers were assumed
to occupy 750 and 2250 A2 (based on dimer's cross-sectional area
(Sefton and Antonacci, 1984)) of the Teflon surface, respectively, so
the concentration of destabilizing interfacial sites was calculated by
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dividing the unoccupied surface area (A2 /ml) by 2000 A2/site. As
the concentrations of dimers and hexamers decreased, more
interfacial sites were freed up, leading to a greater number of
destabilizing interactions between insulin monomers and the
hydrophobic surface.
5.2.5 Rate Constants for the Formation of
Intermediates and Aggregated Species
Rate constants for steps 5 and 6 (Table 5.2) were empirically
determined based on one data set: Zn-insulin with 10 Teflon spheres
at 80 RPM and 37 0 C, assuming K6ads=0. 4 xK2ads). These parameters
had to be internally consistent, with kU-form being greater than kU-
diss (to allow for the formation of stable intermediate species) and
kU-form being greater than kagg (to prevent transient intermediates
from reacting with native species). Once determined, these pseudo-
rate constants remained unchanged in all subsequent simulations,
and only those parameters which could be measured or estimated
independently (such as insulin concentrations, hydrophobic surface
areas, Zn2 + content, and agitation rates) were varied. These external
perturbations should have had no effect on the rates of intermediate
formation and aggregation (since those intermolecular interactions
were diffusion controlled), and hence the constants determined for
one set of conditions should have been valid throughout. The good
agreement between experimental results and computer simulations
indicated that this assumption was reasonable and that our model
was an adequate representation of insulin aggregation in aqueous
solutions.
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5.3 Results of Computer Simulations
5.3.1 Comparison of Na- and Zn-insulin Aggregation
It came as no surprize that results of computer simulations for
Zn-insulin aggregation (10 Teflon spheres, 370 C and 80 rpm) were in
good agreement with experimental observations (Figure 5.2). The
kinetic parameters were determined based on this set of conditions,
with rates of intermediate and aggregate formation chosen to
simulate the relative durations of the induction and aggregation
periods of insulin destabilization.
The same set of parameters (with the exception of Khex) was
used to simulate Na-insulin aggregation (Figure 5.2). The model
predicted that in the absence of Zn2+, higher monomer concentrations
led to faster destabilization and aggregation. As the equilibrium
constant for hexamer formation decreased, the induction period
became shorter and the slope of the curve became steeper.
Computer simulations of Na-insulin aggregation were in good
qualitative and quantitative agreement with the experimentally
determined kinetic profile.
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Figure 5.2: Mathematical modelling of aggregation in Na-(D) and
Zn-(O) insulin solutions agitated at 370C and 80 rpm, in the presence
of 10 Teflon spheres. Results of computer simulations are depicted
by solid lines.
5.3.2 Concentration Dependence in the Presence of
Teflon
The kinetic scheme had to explain the observed concentration
dependence of insulin aggregation rates. As can be seen from Figure
5.3, the model predicted both the characteristic curve shape (an
initial lag time followed by a sloping sections) and increased solution
stability at higher insulin concentrations. During the computer
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simulations, all kinetic and thermodynamic parameters were kept
constant; the only parameter that did change was the number of
insulin molecules present in the beginning of each experiment. The
close agreement between theoretical predictions and experimental
results suggested that the model was a reasonable kinetic
representation of Zn-insulin aggregation upon shaking in the
presence of Teflon.
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Figure 5.3: Mathematical modelling of concentration dependence of
Zn-insulin aggregation. Samples containing 0.6 mg/ml (A), 0.4 mg/ml
(0) and 0.2 mg/ml (0) were agitated at 370C and 80 rpm in the
presence of 5 Teflon spheres. Results of computer simulations are
depicted by solid lines.
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5.3.3 Role of Teflon Surface Area
The proposed kinetic scheme was used to predict changes in
insulin, aggregation rates when Teflon surface area was reduced from
10 to 5 spheres per sample (Figure 5.4). All kinetic and
thermodynamic parameters were kept constant during these
simulations; the only parameter that changed was the concentration
of initially available interfacial sites.
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Figure 5.4: Mathematical modelling of Zn-insulin aggregation in the
presence of 5 (A) and 10 (0) Teflon spheres, at 370 C and 80 rpm.
Results of computer simulations are depicted by solid lines.
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The model predicted the increased induction period and
decreased slope steepness which were observed in insulin samples
containing 5 Teflon spheres. Results of computer simulations were in
good agreement with the experimentally determined concentration
profiles.
5.3.4 Role of Agitation Rate
The effects of increased agitation on Zn-insulin aggregation
rates were modelled by changing Kdenat in proportion to the
increases in the mass transfer coefficient. To evaluate the
dependence of mass transfer coefficient on rates of agitation, several
models were considered. At small mass-transfer rates and constant
surface temperature and composition, forced convection around a
sphere of diameter D could be described as
kinD =2.0 + 0.60 (Bird et al., 1960) (5.8)
cfvABf 'f PDAB
where
km = mass transfer coefficient
cf-= bulk fluid concentration
vo = approach velocity
D ABf = diffusion of components A and B relative to bulk flow
pf = fluid density
127
if = fluid viscosity
1PAB = Schmidt number for the fluid
Equation 5.8 indicated that km was proportional to 4(v.). A
similar dependence of the mass transfer coefficient on the square
root of fluid velocity was found when km was calculated using the
Sherwood number (Sh) for mass transfer in a fluidized packed bed:
Sh = 1.8 Re0. 5Sco .33 *= km (Froment and Bischoff, 1979) {5.9}
where Re and Sc were the Reynolds and Schmidt numbers for the
fluid.
Equations 5.8 and 5.9 suggested that when the agitation rate
was increased from 80 to 160 rpm, Kdenat should have increased by
a factor of 42. It should be noted, however, that the aforementioned
analyses described mass transfer under conditions analogous to, but
not exactly like the ones used in the kinetic studies; they also
neglected the contribution of shear denaturation to monomer
destabilization.
Since an exact analytical relationship between mass transfer
and agitation rates was not available in the literature, Kdenat was
increased by a factor of 2 when the agitation rate was doubled from
80 to 160 rpm. This change was proportional to the increase in the
mass transfer coefficient calculated using equations 5.8 and 5.9; it
128
= 0.6
E
E
cc
*" 0.3
0
_• nn
0 12 24
Hours
Figure 5.5: Mathematical modelling of Zn-insulin aggregation in
solutions agitated at 80 (0) and 160 (0) rpm (in the presence of 10
Teflon spheres, at 370 C). Results of computer simulations are
depicted by solid lines.
also compensated for the possible increase in shear denaturation at
higher agitation rates. Figure 5.5 illustrates that insulin aggregation
at 160 rpm could be successfully modeled with Kdenat = 4x10- 1 6
ml/site. The simulated profile was in good qualitative agreement
with the experimentally observed changes in aggregation kinetics.
The increase in Kdenat led to a reduced induction period and a
steeper slope, characteristic of faster aggregation at increased
agitation rates.
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5.3.5 Aggregation in the Presence of Polypropylene
When Teflon spheres were replaced with polypropylene, mass
transfer in insulin samples changed drastically. Polypropylene's low
density reduced agitation to a minimum; in fact, movement of the
spheres was barely noticeable, making it extremely difficult to
estimate the rates of mixing in these samples. Insulin's interactions
with polypropylene were assumed to be qualitatively similar to
those at the Teflon surface, and as no detailed information was
available about insulin adsorption on polypropylene, adsorption
coefficients were left unchanged.
Mathematical simulation of insulin aggregation in the presence
of polypropylene (Figure 5.6) was accomplished by changing only
one model parameter, Kdenat, which was reduced to 5.5x10-17
ml/site to reflect the decreases in mass transfer and shear effects.
This change in Kdenat was sufficient to desribe the increased
induction period and the reduced slope steepness of the
experimentally determined kinetic profile.
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Figure 5.6: Mathematical modelling of Zn-insulin aggregation in the
presence of Teflon (0) and polypropylene (A). Samples containing
10 spheres were agitated at 370C and 160 rpm. Results of computer
simulations are represented by solid lines.
5.4 Conclusions
The proposed kinetic scheme was successful in predicting
and/or simulating insulin aggregation in the presence of solid
hydrophobic surfaces. It was a minimal kinetic model, containing the
fewest number of steps required to adequately describe system
dynamics. The close agreement between empirical observations and
theoretical predictions suggested that the model provided a
reasonable description of pathways and interactions leading to
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instability, and that it could be used to predict the effects of
stabilizing reagents on insulin's aggregation behavior. The insights
provided by mathematical modelling of reaction kinetics could be
used to select stability enhancing conditions and to design additives
aimed specifically at blocking unfavorable interactions. Computer
simulations also allowed a separate evaluation of the contributions
made by different pathways to the overall pattern of instability
(Appendix B). This analysis could be used to identify the pathways
most sensitive to perturbations, and to propose and test ways to
mitigate destabilizing interactions.
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CHAPTER 6.
STABILIZATION STUDIES
6.1 Stabilization Strategy
The ultimate goal of this work was to enhance insulin solution
stability, and to do so with a clear understanding of the aggregation
mechanism. The stabilization strategy was to target the destabilizing
pathways and to prevent, or eliminate altogether, the unfavorable
interactions leading to insulin aggregation. Since the proposed
kinetic model appeared to be in good agreement with experimental
observations, stabilization efforts were aimed at minimizing insulin
denaturation at hydrophobic interfaces. The model suggested that
these interactions initiated the process of aggregation, and that
solution stability would be improved if contacts between insulin
molecules and hydrophobic surfaces could be eliminated. In fact,
experiments with hydrophilic glass beads showed that no
aggregation occurred in the absence of solid hydrophobic surfaces
(section 4.4.2).
Results of kinetic studies described in chapter 4 indicated that
similar pathways were responsible for destabilization in the presence
of both solid and gaseous hydrophobic surfaces. Thus, similar
stabilization strategies should have succeeded in preventing
aggregation induced by both air-water and Teflon-water
hydrophobic interfaces. Since air could not be eliminated in insulin
vials used in the traditional injection therapy for diabetes mellitus,
stabilization studies aimed to reduce insulin aggregation in the
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presence of an air-water interface. The addition of surface active
reagents, which would occupy interfacial sites and minimize insulin's
contacts with a hydrophobic surface, was expected to enhance
solution stability.
6.2 Materials and Methods
6.2.1 Control Studies with an Air-Water Interface
(Bovine Zn- and Human Na-insulin)
Stock solutions were prepared as described in section 3.3.2,
using bovine Zn-insulin (Sigma, lot 79F-0092 {25.7 IU/mg}) and
human Na-insulin (Lilly Labs, lot 048 EMO). Samples were prepared
by adding 4.0 ml of stock solution to borosilicate glass culture tubes
(Pyrex, 12x75 mm), which were capped with polyethylene stopper
pugs and agitated at 100 rpm and 370 C. QELS and UV analyses were
performed every hour. Sample volume and agitation rate were
optimized for maximum reproducibility and rapidity of aggregation.
6.2.2 Stabilizing Reagents
To improve insulin stability, small amounts of surfactants were
added to protein solutions. Since insulin was negatively charged at
neutral pH, cationic surfactants precipitated it from solution and
could not be used. Some anionic detergents (e.g., SDS) had been
previously shown to reduce insulin aggregation, but at concentrations
too high (1 wt%) to be physiologically compatible (Lougheed et al.,
1983). It was therefore of interest to explore the stability enhancing
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properties of compounds which had low toxicity and could be used at
low concentrations.
The effects of nonionic detergents on insulin solution stability
were examined in the presence of an air-water interface at 100 rpm
and 370 C. Most of the reagents (Table 6.1) were used at
approximately one half of critical micelle concentration (CMC) to
examine the interactions with the air-water interface and to prevent
micelle formation from interfering with the QELS analysis.
- - - Q .. ,--- - - - - - - - -m - - - - - - - - - - - - - - - m - - m m - - -
Table 6.1: Nonionic detergents used in preliminary stabilization
studies.
Detergent Source Lot number CMC
n-octyl-B-D-glucopyranoside Sigma 60H5010 19-25 mM*
n-dodecyl-B-D-maltoside Sigma 110H5013 120 gMM*
Brij-35 Sigma 10H0353 100 pM t
Tween 20 Sigma 7010171 59 pMt
Pluronic F68 Calbiochem 018191 NAt
Pluronic F127 Calbiochem 910104 NAt
* CMC at neutral pH and 1=0.10 (Neugebauer, 1988).
t CMC at neutral pH and 1=0.05 (Neugebauer, 1988).
* No CMC values were available for these reagents, which were used
at concentrations recommended by (Chawla et al., 1985) (2x insulin
concentration).
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To determine whether the addition of another protein to
insulin solutions would reduce aggregation, 30 mg/ml (0.45 mM) of
BSA (Sigma) was co-dissolved with 0.6 mg/ml (0.10 mM) insulin in
PBS. If BSA preferentially adsorbed at hydrophobic interfaces, it
would reduce the number of unfavorable contacts leading to insulin
denaturation. This competition for interfacial sites was expected to
contribute to solution stability.
6.2.3 Surface Tension Effects
Surface tension of Zn-insulin solutions (0.6 mg/ml in PBS) was
varied by adding 1% (w/v) of either acetonitrile (Baker, HPLC grade)
or n-propanol (Mallinckrodt, analytical grade). Sample preparation
and experimental conditions were the same as in air-water
interfacial studies.
6.3 Results of Preliminary Stabilization Studies
In the absence of nonionic detergents, Zn-insulin solutions
aggregated in 24 hours (Figure 6.1 A). Both the formation of stable
intermediates species (Figure 6.1 B) and the characteristic curve
shape were observed, with the induction period lasting
approximately 6 hours, and a tl/2 value of 12 hours.
The addition of proposed stabilizing reagents had variable
effects on overall solution stability. Solutions containing n-octyl-B-D-
glucopyranoside (10 mM), n-dodecyl-8-D-maltoside (100 gM) and
Brij 35 (50 gM) showed no signs of aggregation even after seven
days (Figure 6.2), while solutions with Tween 20 (30 pM), Pluronic
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Figure 6.1: Zn-insulin aggregation in the presence of an air-water
interface at 370 C and 100 rpm. (A) Time-dependent concentration
profile; (B) results of QELS analysis after 2 hours of agitation.
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68 (200 gM) and Pluronic 127 (200 gM) aggregated after 72, 50 and
36 hours, respectively (Figure 6.3). The presence of BSA had no
effect on insulin soltution stability: insulin solutions with and without
BSA aggregated in approximately 24 hours (Figure 6.3).
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Figure 6.2: Stability of aqueous solutions of Zn-insulin (agitated at
100 rpm and 37 0 C in the presence of an air-water interface)
containing no additives (*), Brij 35 (0), n-octyl-B-D-glucopyranoside
(A), and n-dodecyl-B-D-maltoside (A). Results of a seven day study.
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Figure 6.3: Stability of aqueous solutions of Zn-insulin (agitated at
100 rpm and 370 C in the presence of an air-water interface)
containing no additives (*), Tween 20 (0), Pluronic F68 (A), Pluronic
F127 (E), and BSA (0). Results of a three day study.
6.4 Mechanism of Stabilization
Nonionic detergents were expected to improve solution
stability because of their affinity for the hydrophobic interface,
where the hydrophilic head groups faced the aqueous environment,
while the hydrophobic tails extended into the gaseous phase (Figure
6.4). As a result, insulin would be excluded from the interface and,
consequently, its adsorption induced conformational changes would
be minimized.
139
Figure 6.4: (A) Surfactant molecules' orientation at and occupation
of the air-water interface; (B) schematic representation of a
surfactant molecule.
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6.4.1 Good vs Poor Stabilizing Reagents
It became clear from the initial stabilization studies that some
of the tested detergents were much more effective in preventing
insulin aggregation. To explain the differences in their stability
enhancing properties, molecular structures of these reagents were
examined (Figures 6.5 and 6.6). The smaller, less sterically hindered
surfactant molecules (Figure 6.5) could easily orient themselves at
(and fully occupy) the air-water interface, which is probably why
they exerted the most dramatic stabilizing effects. In contrast, such
bulky nonionic detergents as Tween 20 and Pluronic 127 (Figure 6.6)
may not have been closely packed at the interface because of steric
factors. This inability to fully cover the hydrophobic surface
probably impaired their stability enhancing properties.
BSA's inability to prevent aggregation was not surprising.
Insulin was a much more hydrophobic molecule than BSA, and
probably had a higher affinity for the air-water interface. BSA's
polar surface made interactions with hydrophobic surfaces
thermodynamically unfavorable, leaving insulin's cLntacts with the
air-water interface unchanged even at relatively high concentrations
of BSA.
141
HO-CH 2
'KNO-(CH2)7CH3I
H '/ n-octyl-H-D-glucopyranoslde
SH
HC HO-CH 2
O~-(CH 2)11CH 3
CH 3 (CH 2) 11-O(CH 2CH20) 2 3- H%FWAAAJH
O
CH3(CH2)11 '0' -O'Na+
n-dodecyl-1B-D-maltoside
Brij 35
SDS
Figure 6.5: Molecular structures of detergents which enhanced
insulin solution stability. The hydrophobic portions of the molecules
are underlined.
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Figure 6.6: Molecular structures of detergents which failed to
improve insulin solution stability.
molecules are underlined.
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6.4.2 Role of Surface Tension
It was suggested previously that insulin stabilization in the
presence of surfactants was partly due to reduced surface tension
(Lougheed et al, 1983), which minimized shear denaturation effects
at the air-water interface. However, the addition of 1 wt% of n-
propanol (which reduced surface tension (Weast, 1978) in the
absence of a surface active reagent) did not increase solution
stability; quite the contrary, it resulted in faster aggregation (Figure
6.7). At the same time, the addition of 1 wt% of acetonitrile had
practically no effect on either surface tension (Weast, 1978) or
aggregation (Figure 6.7). In the presence of n-propanol, lowered
surface tension increased the air-water interface available to
destabilize insulin monomers, thus leading to more rapid aggregation.
It should be noted that both n-propanol and acetonitrile had
denaturing properties (Musial et al., 1986); however, in the unlikely
event that the small amounts (1%) added actually contributed to
monomer denaturation in solution (rather than at the air-water
interface), similar destabilizing effects should have been observed
with both reagents. Since insulin aggregation was not affected by the
addition of acetonitrile, denaturation in bulk solution could be
dismissed, and increased aggregation with n-propanol attributed to
decreased surface tension.
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Figure 6.7: Effects of surface tension (values depicted in the figure)
on insulin aggregation rates (air-water interface, 100 rpm, 37 0C): no
additives (U), 1 wt% n-propanol (A), 1 wt% acetonitrile (0).
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6.5 Long Term Stabilization with Bovine Zn-Insulin
The results of preliminary stabilization studies indicated that
Brij 35 and the sugar-based detergents n-octyl-B-D-glucopyranoside
and n-dodecyl-B-D-maltoside significantly reduced insulin's
propensity to aggregate even in the presence of elevated
temperature, agitation and an air-water interface. To further explore
the stability enhancing properties of these three surfactants, a long
term study was undertaken. Samples were prepared as described in
section 6.2; UV and HPLC analyses were performed every two days
during the first four weeks, and every seven days thereafter.
As can be seen in Figure 6.8, no aggregation was observed in
samples containing n-octyl-B-D-glucopyranoside or n-dodecyl-B-D-
maltoside, and no intermediate species were detected in them. In
the presence of Brij 35, the onset of aggregation was delayed, with
the induction period lasting over 10 days. After 12 days of agitation,
large intermediate species were detected and insulin concentrations
began to decrease; these insulin samples aggregated completely
within 2 weeks. The difference in the stability enhancing properties
of these surfactants could probably be attributed to their structural
differences. Brij 35 (by far the largest and bulkiest molecule of the
three) was probably less effective in excluding. insulin from the
hydrophobic surface, allowing a few protein molecules to interact
with the air-water interface. The slow destabilization of these
molecules probably led to the subsequently observed aggregation.
The stabilizing effects of sugar-based nonionic detergents are
particularly encouraging. Since elevated temperatures contribute to
insulin destabilization, one can expect that the stabilization observed
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Figure 6.8: Long term stability of aqueous solutions of bovine Zn-
insulin (agitated at 100 rpm and 370 C in the presence of an air-water
interface) containing no additives (0), Brij 35 (0), n-octyl-B-D-
glucopyranoside (A), and n-dodecyl-B-D-maltoside (A). (A) Time-
dependent concentration profiles; (B) results of QELS analysis.
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with these reagents at 370C could be enh'.nced still further at room
temperature.
6.6 Long Term Stabilization with Human Na-Insulin
In the absence of stabilizing reagents, solutions of bovine Zn-
insulin aggregated within a day (Figure 6.1). Human insulin (which
is more hydrophilic and hexamerizes less readily than its bovine and
porcine counterparts (Brange et al., 1990)) had been shown to be
slightly more prone to aggregation and destabilization. The reduced
stability was attributed to higher monomer concentrations; at the
same time, insulin dissociation to monomeric and dimeric species was
desirable, since it facilitated adsorption into the bloodstream and
provided better glycemic control (Brange et al., 1990). Since the
development of genetic engineering techniques, insulin preparations
have been formulated using recombinant human insulin, making the
stability of this species an immediate concern for diabetes therapies.
To examine the stability of this recombinant protein, solutions
of human Na-insulin were tested with and without stabilizing
reagents. Samples containing no additives aggregated in
approximately 7 hours (Figure 6.9 A). The induction period was
reduced to less than one hour, and tl/2 of approximately 4 hours was
observed. This behavior was very similar to the aggregation of
bovine Na-insulin in the presence of Teflon (section 4.3.4). The
reduced concentration of hexamers was evident from the QELS
analysis (Figure 6.9 B): here too the native peak shifted from 5 to 4
nm, indicating the predominance of dimeric and monomeric species
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Figure 6.9: Human Na-insulin aggregation in the presence of an
air-water interface at 370C and 100 rpm. (A) Time-dependent
concentration profile; (B) results of QELS analysis after 2 hours of
agitation.
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(see 4.3.4 and Appendix A for a more detailed discussion of QELS
results). QELS also detected stable intermediate species (indicated by
the peak at approximately 200 nm) in solutions of aggregating
human Na-insulin.
To reduce aggregation, n-octyl-B-D-glucopyranoside and n-
dodecyl-B-D-maltoside (which demonstrated the best stability
enhancing properties) were added to solutions of human Na-insulin.
During this long term study, UV and QELS analyses were performed
on duplicate samples twice a week. As can be seen from Figure 6.10,
samples containing 100 I.M n-dodecyl-B-D-maltoside remained
stable for almost two weeks, at which point the majority of these
samples aggregated. In the presence of 10 mM n-octyl-B-D-
glucopyranoside, no aggregation was observed during the 6 weeks of
the experiment.
Although these nonionic detergents significantly improved the
stability of both human and bovine insulin, there were some notable
differences between the stabilization of Na- and Zn-insulin solutions.
Both n-octyl-B-D-glucopyranoside and n-dodecyl-B-D-maltoside were
equally effective in preventing insulin aggregation in solutions
containing Zn2 +. However, in the absence of Zn2+, n-dodecyl-B-D-
maltoside failed after two weeks, while n-octyl-B-D-glucopyranoside
continued to protect insulin stability for six weeks. The molecular
structures of the two surfactants were not significantly different (the
maltoside's hydrophobic tail was slightly longer and its hydrophilic
head group slightly larger than the respective portions of the
glucoside molecule), and should not have caused large differences in
their interactions with the air-water interface. The success of both
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Figure 6.10: Long term stability of aqueous solutions of human Na-
insulin (agitated at 100 rpm and 370 C in the presence of an air-water
interface) containing no additives (0), n-octyl-B-D-glucopyranoside
(A), and n-dodecyl-B-D-maltoside (A). (A) Time-dependent
concentration profiles; (B) results of QELS analysis. Results were the
averages of two measurements, with error bars representing
standard deviation from the mean.
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reagents in Zn-insulin solutions also supported the conclusion that
something other than structural differences compromised the
effectiveness of n-dodecyl-1-D-maltoside in Na-insulin solutions.
In the absence of Zn2 +, the concentration of insulin monomers
became much higher. As a result, the ratio of monomers to
surfactant molecules was approximately 1 to 1 in solutions
containing n-dodecyl-B-D-maltoside, while in the presence of n-
octyl-B-D-glucopyranoside the ratio of surfactant to protein was
closer to 100 to 1. In the presence of maltoside, the monomer had to
compete for interfacial sites with just one surfactant molecule, and
not 100, as was the case in solutions stabilized with glucopyranoside.
This probably made monomer interactions with and denaturation at
the air-water interface much more likely in solutions containing n-
dodecyl-B-D-maltoside.
Although insulin solutions stabilized with n-octyl-B-D-
glucopyranoside did not aggregate during the six weeks of the
experiment, QELS results indicated that some destabilizing
interactions did occur. A small amount of stable intermediate species
(approximately 120 nm in diameter) was observed in some samples
(Figure 6.11). As the formation of this intermediate did not result in
aggregation, it was concluded that it reached neither the critical size
nor the concentration necessary to initiate interactions with native
insulin molecules. It is also possible that this species was formed as
a result of interactions between protein and surfactant molecules
(i.e., micelle formation).
These minor side effects, however, should not detract from the
most important observation that in the presence of n-octyl-B-D-
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unchanged during the 42 days of the experiment.
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Figure 6.11: QELS analysis of human Na-insulin solutions stabilized
with n-octyl-B-D-glucopyranoside (after 14 days of agitation at 100
rpm and 37 0 C, in the presence of an air-water interface). This size
distribution histogram was generated using the program CONTIN.
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6.7 Safety of Stabilizing Reagents
The nonionic surfactants which proved to be particularly
successful in preventing insulin aggregation in agitated aqueous
solutions, have not been approved by the FDA (although Brij 35 was
approved by the regulatory agency of the UK (Pharmaceutical Society
of Great Britain, 1986)). Unfortunately, Tween 20 and Pluronic 68 --
which according to US pharmacopeia (U.S. Pharmacopoeial
Convention, 1979) are safe for use in some drug formulations -- did
not have a satisfactory stabilizing effect on insulin solutions. This
br. ht into question the safety of n-octyl-B-D-glucopyranoside and
n-d odecyl-B-D-maltoside.
One reason why these two surfactants have not yet received
FDA approval is that both are quite new, and have not been used in
drug formulations, finding their primary application in biological
research (where they are used to solubilize membrane proteins
(Gould et al., 1981; Muccio and DeLucas, 1985)). However, if one
compares the structures of these molecules to those of reagents
which are considered to be safe by the FDA (U.S. Pharmacopoeial
Convention, 1979), many similarities can be found. For example, SDS
(an anionic detergent, approved for use in some drug formulations)
has a hydrophobic portion identical to that of n-octyl-B-D-
glucopyranoside, and has a hydrophilic headgroup (SO4-) which
appears to be even less innocuous than the glucose moiety in the
proposed nonionic detergent. Similarly, the hydrophobic tail of n-
dodecyl-B-D-maltoside is slightly longer than that of SDS (by 4
carbon groups), and its hydrophilic headgroup is the maltose moiety,
which would not be expected to cause toxic side effects.
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Furthermore, the concentrations of nonionic surfactants shown to be
sufficient to prevent insulin aggregation were very small (100 gM -
10 mM, compared to 35 mM for SDS (Lougheed et al., 1983)), thereby
reducing the likelihood of toxicity. This also suggested that FDA
approved reagents such as SDS could be used at much lower
concentrations (than previously tested) to stabilize insulin solutions.
Nevertheless, extremely strict standards will be applied to
additives used in insulin formulations, since these pharmaceuticals
are used to treat a chronic illness over a patient's lifetime. If the
proposed nonionic detergents do not meet such stringent
requirements, other (safer) reagents must be found. The following
criteria should be used in selecting stabilizing additives for insulin
formulations: a) they must exhibit high affinity for hydrophobic
interfaces, b) their structure must be compact, allowing them to
easily orient at and fully occupy the hydrophobic surface, c) they
must have no denaturing properties, and should not interfere with
insulin's self-association, and d) they must be nontoxic, and be
required at low concentrations. Reagents which satisfy these
conditions should prevent insulin aggregation in aqueous solutions
exposed to hydrophobic surfaces, as they are targeted at minimizing
monomer denaturation resulting from interfacial contacts.
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CHAPTER 7.
CONCLUSIONS
Stability of protein based pharmaceuticals is essential for their
production, storage, and delivery. The specific formulation of these
therapeutic reagents must anticipate and prevent all unfavorable
interactions which may lead to loss of biological activity. There are
no uniform guidelines for improving protein stability; the diversity
of protein sizes and conformations presents new challenges and
problems specific to the individual molecule. In order to reduce the
amount of guesswork going into the formulation of protein-based
drugs, rational stabilization strategies are needed to address the
specific problems of a particular protein system. All degradation
mechanisms must be explored, so that stability enhancing additives
can be chosen based on their ability to block unfavorable
interactions.
This investigation was aimed at gaining a fundamental
understanding of insulin solution stability and aggregation. The
effects of agitation rates, air-water and Teflon-water interfacial
interactions, insulin concentration, solvent composition, surface
tension and Zn2 + content were examined. Detailed kinetic studies
were performed to determine how these parameters affected the
overall pattern of aggregation. Time dependent concentration
profiles of insulin aggregation were generated, and quasielastic light
scattering measurements were used to monitor changes in particle
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size distribution. Based on the experimentally observed trends and a
comprehensive literature review, a mechanism of insulin aggregation
in aqueous solutions in contact with solid hydrophobic surfaces was
formulated, and mathematical modelling was used to simulate
reaction kinetics.
The proposed reaction scheme incorporated insulin's self-
association equilibrium, and identified monomer denaturation at
hydrophobic interfaces as the step which initiated the process of
destabilization. The model was used to explain both the anomalous
concentration dependence and the initial lag time observed in
aggregating insulin solutions. It correctly predicted trends in insulin
destabilization, and appeared to be valid in the presence of both solid
and gaseous hydrophobic surfaces. Computer simulations helped to
identify the pathways leading to insulin destabilization and
aggregation, and to propose rational stabilization strategies, which
aimed specifically at minimizing or eliminating unfavorable
interactions.
To prevent insulin destabilization induced by contacts with
hydrophobic surfaces, several stabilizing reagents were evaluated.
These nonionic surfactants successfully inhibited monomer
denaturation at the air-water interface, and prevented insulin
aggregation for up to 6 weeks. The stabilization mechanism was
consistent with the destabilizing role attributed to the hydrophobic
surface: only those surfactants able to readily orient themselves at
the interface and thus exclude insulin from surface interaction, were
effective in preventing aggregation. It was also shown that
occupation of interfacial sites, rather than reduction in surface
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tension, enhanced insulin solution stability. It is hoped that better
understanding of the aggregation mechanism and greater
formulation stability may lead to improvements in diabetes therapy,
particularly the design of new devices for prolonged insulin
administration
This work illustrates an engineering approach to improving
protein stability. Rather than rely on empirical stabilization
strategies, this study identified the mechanism of destabilization, and
chose stability enhancing additives which specifically targeted the
unfavorable interactions causing monomer denaturation. Improved
stability was achieved in a controlled and rational manner, bringing
more science to the current "art" of drug formulation.
7.1 Suggestions for Future Work
The current model of insulin aggregation in aqueous solutions
in the presence of solid hydrophobic surfaces allowed one to make
qualitative predictions about trends in aggregation behavior. The
model was particularly successful in describing changes resulting
from variations in insulin concentration and in the size of the Teflon
surface area. However, the experimental system used in this study
did not allow for a separate evaluation of the effects of surface
hydrophobicity and mass transfer on the overall aggregation
behavior. It would be of interest to decouple these two parameters.
To investigate the role of mass transfer (in the presence of a
fixed hydrophobic surface area), another sample geometry could be
chosen, one with well characterized fluid mechanics (i.e., where an
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analytical expression exists to relate the mass transfer coefficient to
fluid velocity). For example, agitation could be provided by a disk
spinning in an enclosed container. Mixing rates could then be varied
by changing the speed of rotation, and the mass transfer coefficient
could be determined analytically.
This system could also be used to study the effects of surface
hydrophobicity. The disk's surface could be modified with different
concentrations of hydrophobic groups, and the degree of
hydrophobicity determined by measuring the contact angle of water
with the surface. Using a fixed agitation rate, insulin aggregation
could be examined in the presence of a range of hydrophobic
surfaces. A better understanding of insulin interactions with
polymer surfaces could also be used to improve insulin stability in
controlled release devices. The same type of analysis could be used
to study other proteins as well, since conformational changes induced
by surface interactions and/or shear denaturation are important
issues for many other protein systems.
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APPENDIX A
PRINCIPLES OF QUASIELASTIC LIGHT SCATTERING
ANALYSIS
This section is intended to be a brief overview of QELS (or
photon correlation spectroscopy); more indepth discussions of light
scattering theory and interpretation of QELS results can be found in
the references sited herein.
A.1 Theoretical Basis for Particle Size Determination
Quasielastic light scattering is a non-invasive technique
(Weiner, 1984) which allows one to measure the size of particles
smaller than 1 micron. A typical experimental set-up used for
making light scattering measurements is depicted in Figure A.1: a
laser beam shines on a static sample; the light scattered at an angle 0
(90' in this study) is collected by the photomultiplier, and the output
is analyzed by an autocorrelator. This analysis assumes that incident
and scattered light are of the same wavelength.
If the particles in the sample are much smaller than the laser
wavelength X, they re-radiate like small dipoles (Weiner, 1984).
Since the dissolved particles undergo diffusion (Brownian motion),
their relative positions are constantly changing, causing
instantaneous fluctuations in the signal detected by the
photomultiplier. These fluctuations are detected as noise in the
scattered radiation (Figure A.2). The autocorrelator analyzes
scattered data by comparing the photomultiplier output (scattering
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Figure A.1: Schematic representation of the experimental set up
used to make light scattering measurements.
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Figure A.2: Schematic representation of QELS analysis.
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intensity I) at some time t with the output at time (t + r):
If the outputs are similar at the two times, they are said
to be correlated. If the motion of the scattering particle
is rapid compared to r, then there will be no average
correlation between the two output levels. If the motion
is slow compared to r, there will be, on average, a
correlation between the output levels at time t and (t + r)
[which is why the choice of At (sample time) is extremely
important for making meaningful QELS measurements].
This correlation is defined by a function g(r). It is
common for the correlation function g(r) to decrease
exponentially with increasing t. The time constant of the
decay is related to the product of the scattering vector q
and the diffusion coefficient D. Thus,
g(r) = e-Dq 2  {Al }
A plot of ln{g(t)} versus r then gives a straight line with
slope -Dq2 (Cantor and Schimmel, 1980).
The scattering vector q is a function of the solvent's index of
refraction n, the scattering angle 0 and the wavelength X of the
incident light:
q =f 4Lnsin-Q-
X 2 {A2}
which is a constant for a given set of experimental conditions. The
translational diffusion coefficient 0 can then be determined from
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equations Al and A2. The Stokes-Einstein equation relates the
hydrodynamic radius Rh to the diffusion coefficient as follows:
DT= kT
6x7TRh {A3}
where k = Boltzman constant
T = absolute temperature
1 = solvent viscosity
Rh= radius of a spherical particle
For monodisperse solutions of spherical particles, this analysis
provides a rapid and accurate (±3% (Brookhaven, 1986)) method for
particle size determination. For non-spherical particles, it calculates
an Rh which is defined as the product of the radius of a sphere with
the equivalent volume (Re) and a form factor fo 21 (which becomes
very large when the shape of the particle deviates significantly from
a sphere) (Degiorgio, 1980). Thus, the accuracy of the analysis
decreases as the uncertainty about the particle shape increases. For
polydisperse solutions, QELS can also be used to determine
approximate particle size distributions (see A.3 Signal Processing).
Note that this technique is different from classical light
scattering, which averages out the fluctuations in the signal and uses
time averaged intensity <Is> to determine molecular weight and
radius of gyration (from angle dependent intensity measurements).
Classical light scattering is particularly useful for monodisperse
solutions, since information about sample polydispersity is lost
during signal averaging. When combined with an appropriate
180
separation technique (such as GPC or HPLC), classical light scattering
can be used to determine molecular weight distributions by
calculating weight averaged molecular weights for the individual
peaks.
A.2 Scattering from a Single Particle
For spherical particles, scattering intensity can be represented
by (Weiner, 1984)
<I>i =o NiMi2Pi(0) {A4}
where N = number of particles
M = particle mass
P(O) = general form factor at the scattering angle 0
It follows that scattering intensity is proportional to particle
diameter d raised to the sixth power, which is why high intensity
laser sources are required to measure submicron-size particles. This
dependance of scattering intensity on d6 also explains why this
analysis is extremely sensitive to dust content in the sample: the
signal contributed by these large particles can be so strong as to
completely overshadow the scattering from the small particles being
examined. The scattering also depends upon the differential
refractive index (dn/dc) of the particle with the surrounding medium
and concentration (i.e., a large dn/dc facilitates the detection of a
particle in a given solvent, while if the ratio is not sufficiently big, it
becomes impossible to distinguish between the signal emanating
from solvent and solute molecules).
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Let's consider the case of a polydisperse solution of Zn-insulin
monomers, dimers and hexamers. The total scattering intensity is
Itotal = Imon + Idim + Ihex {A5}
where Imon " Nmonx(dmon) 6
Idim " Ndimx(ddim) 6
Ihex " Nhexx(dhex) 6
At 0.6 mg/ml, there were 2.5x10 15 monomers, 6.4x10 14 dimers
and 9.4x1015 hexamers per ml of insulin solution, with diameters of
2, 3 and 5 nm, respectively (Blundell et al., 1972). Thus, the relative
scattering of monomer to hexamer molecules could be calculated as
Imon_=2.5x10 15 x(2)6 =- 0.001
Ihex 9.4x10 15 x(5)6 {A6}
and the relative scattering of dimeric to hexameric particles as
Idm 6 .4 x1014x(3) 6 = 0.003
Ihex 9.4x10 15x(5) 6  {A7}
This clearly illustrates that the signal from solutions of Zn-
insulin was dominated by the scattering caused by the hexameric
species, as was evident from the peak centered at 5 nm (Figure 4.5).
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The miniscule contributions to total scattering intensity by the
dimers and monomers (0.3 and 0.1%, respectively) explain why it
was impossible to distinguish among these species in solutions of Zn-
insulin.
A.3 Signal Processing
The time-dependent intensity fluctuations detected by the
photomultiplier can be represented by a second-order intensity
autocorrelation function (Yarmush et al., 1988)
T
G( 2)(r)= (I(t)I(t+r)) = t.I I l I(t)I(t+r)dt {A8}
where T is the duration of the experiment, and G( 2 )(r) is the time
average intensity evaluated at various values of r. In practice, the
integral in equation A8 is approximated by a sum of discrete values
(i.e. the number of photons ni counted by the photomultiplier during
a time interval Ar) (Yarmush et al., 1988). A8 can then be
represented by (Stock and Ray, 1985)
) lir iN
G(2 j) ninim i+j (nini+j) {A9}
N-4oo Ni=
where At is the sample time, N the total number of samples, and r=jAr
the autocorrelation delay time, with j taking integer values from 1 to
m (m being the number of correlator channels). A normalized second
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order intensity autocorrelation funmtion is obtained by dividing
G( 2)(,) by the baseline value
g (2)( G (2)(T) =ni ' n i+j  {fAlO}
G(2)(.) (n)
In this study, G(2 )(,) was determined using the first 135
channels of the autocorrelator, while the baseline G(2)(00) was
measured by the last 6 of 8 channels delayed by 1024 sample
periods (Brookhaven, 1986).
For a dilute solution of independently scattering
macromolecules, the electric field of the scattering light is a Gaussian
random process (Yarmush et al., 1988), for which the Siegert relation
g(2 )(r) = 1 + B1 g( 1)(t) 12 {Al }
may be derived; (B is an experimental variable (0<B<1) limited by the
signal-to-noise ratio of the measurement system) (Stock and Ray,
1985).
A.3.1 Polydispersity Analysis
If the Siegert relation applies, the electric field autocorrelation
function can be represented as a sum or a distribution of single
exponentials:
g1)(l)=;fG(y)exp(-yr)dy {A12}
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The distribution G(y)dy is the fraction of the total
integrated intensity scattered by particles which obey
y= D q2 within the interval dy, where D is the diffusion
coefficient and q is the scattering vector defined in
[equation A2]. For spherical particles, the radius is
related to diffusion coefficient through the Stokes-
Einstein formula [equation A3].
To find a size distribution from [QELS] data, one
must transform the measured intensity autocorrelation
function into an electric field autocorrelation function
using equations [A10 and All]. Then the task of each of
the data interpretation methods is to invert equation
[A12] to obtain G(y) from electric field autocorrelation
data g(1)(r).
Unfortunately, the inversion of the integral
equation [A12] is in general an ill-posed problem. There
are, in principle, an infinite number of solutions G(y)
which will satisfy equation [A12] to within experimental
error present in g(l)(,). Hence, it is necessary t, put
some reasonable constraints on G(y) in order to find a
unique solution. Two strategies are useful: (i)
incorporation of a priori information [i.e., non-negativity
of G(y)], and (ii) parsimony, which requires that the
simplest of all possible solutions be chosen. (Stock and
Ray, 1985).
The polydispersity analysis can resolve between two
populations of particles only if their ratio of sizes exceeds 1.5
(Brookhaven, 1986). The determination of size distribution is further
complicated by the presence of non-Rayleigh scatterers (particles
larger than X/10), when back-scattering and other interference
effects must also be considered (Degiorgio, 1980). These effects can
be taken into account by evaluating the 0-dependent form factor P(0)
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(see equation A4) using the relationship derived by Gustave Mie in
1908. The complete treatment, which includes the distortion of the
electric field of the incident radiation produced by the difference
between the refractive index of the particles and the solvent, is
exceedingly complicated (Tanford, 1961).
In this work, particle size distributions were determined using
Non-Negatively Constrained Least Squares (NNLS) and Constrained
Regularization (CONTIN, of Provencher) algorithms. For a detailed
discussion and comparison of the two methods, please see (Stock and
Ray, 1985). In general, there was good agreement between the
results of these inversion schemes. However, since CONTIN used
parsimony in choosing a solution, it often smoothed out the particle
size distribution (i.e., instead of reporting peaks at 5 and 30 nm, only
one broad peak (4-40 nm) centered at 15 nm was detected). The
NNLS method was particularly useful for multimodal distributions
with narrow, widely spaced peaks, which was the case in this study
(i.e. native peaks at 5 nm and intermediate peaks at 170±20 nm).
Nevertheless, the uncertainty about the shape of the intermediate
species prevented a quantitative determination of its size and weight
distribution.
A.4 Concluding Remarks
It is important to emphasize that the accuracy of the inversion
algorithms depends on the quality of the measured autocorrelation
function. To ensure the reliability and reproducibility of QELS
measurements, great care was taken to prepare dust-free samples, to
control sample temperature, to increase the signal-to-noise ratio, and
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to choose appropriate duration and sample times. For polydisperse
samples, multiple sample times were used (ranging from 0.5 to 40
psec), so that the autocorrelation function contained sufficient
information about both small (5 nm) and large (-200 nm) particles
present in solution.
QELS analysis can be a powerful tool for studying physical
properties of macromolecules. However, it is important to remember
the limitations of this technique and to refrain from overinterpreting
the results of light scattering measurements (particularly when a
polydispersity analysis is involved). It is advisable to measure
particle sizes using other techniques (i.e., SEM, HPLC, etc.) to confirm
QELS results. In this study, the sizes of native insulin species were
known from the literature, and QELS measurements were found to be
in good agreement with the reported values. However, the
intermediate species were present in such low concentrations (less
than O.1wt%) that detection by other methods was impossible. The
formation of particles larger that the 5 nm hexameric species was
evident not only from the size-distribution analysis, but also from
the shape of the autocorrelation function, the increased scattering
intensity, and the need for larger sample times. The fact that the
intermediates were detected in all aggregating insulin solutions also
indicated that the peak at -170 nm was not an artifact of the
inversion algorithm, but represented a real, physical entity.
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APPENDIX B
SENSITIVITY ANALYSIS
It was of interest to determine model sensitivity to changes in
the values of kinetic and thermodynamic parameters. To identify
the reaction steps most affected by perturbations, computer
simulations were performed using various magnitudes of a particular
rate or equilibrium constant. This analysis provided additional
insights into the nature of the aggregation process, because it allowed
a separate evaluation of the contributions of different pathways to
the overall pattern of instability.
None of the simulated perturbations changed the shape of the
kinetic profile, i.e., the initial period of stability, followed by a
slightly sigmoidal curve. However, the duration of the induction
period, the steepness of the slope, and the relative durations of the
two phases of aggregation did change.
B.1 Model Sensitivity to Fitted Kinetic Parameters
The kinetic parameters kU-form and kagg were determined
based on the results obtained with aqueous Zn-insulin solutions
agitated at 370C and 80 rpm, in the presence of 10 Teflon spheres.
Since these empirically fitted parameters differed only by an order
of magnitude, it was impossible to significantly change one without
compromising the internal consistency of the proposed aggregation
mechanism. However, as long as these constants remained within
the specified order of magnitude range, it was possible to test model
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Figure B.1: Model sensitivity to changes in the rate constant of
intermediate formation (kU-form). Computer simulations were done
using: the model value (0), 1/2 of the model value (A), and twice the
value used in the model (0).
sensitivity to such variations. Changes in kU-form affected the
duration of the induction period and the slope of the curve (Figure
B.1). This reflected the fact that the aggregation rate was affected
both by the rate of intermediate formation and the concentration of
the intermediate species.
These effects would have been less pronounced if the size of
the intermediate species had been on the order of 100 (rather than
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10) molecules. The value of the pseudo-rate constant used in the
model was significantly lower than the actual value (which could not
be estimated because of the uncertainty about the size and shape of
the intermediate species). Thus, it took the same amount of time to
reach the critical size U10 in the model as it did to reach -U100 in the
actual reaction. The sensitivity analysis illustrated that
underestimating the value of kU-form affected the overall kinetic
pattern to a greater extent than overestimating this rate constant.
Variations in the rate of aggregate formation (kagg) had very
little effect on the kinetic profile (Figure B.2). Changes in the
duration of the induction period were barely noticeable, but the
steepness of the slope changed slightly, while the overall pattern of
aggregation remained the same. Since the steepness of the slope
represented the rate of aggregation following the formation of the
intermediate species, it was not surprising that changes in kagg
affected this portion of the kinetic profile.
Because of the uncertainty about the actual values of the
kinetic constants, the model was used to make only qualitative
predictions about Zn-insulin aggregation. This sensitivity analysis
confirmed that the overall pattern of the reaction was independent
of the values of the fitted rate constants, and that mathematical
modelling could be used to identify trends in insulin aggregation.
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Figure B.2: Model sensitivity to changes in the rate of aggregate
formation (kagg). Computer simulations were done using: the model
value (0), 1/2 of the model value (A), and twice the value used in
the model (0).
B.2 Model Sensitivity to Changes in Equilibrium
Constants for Self-Association
The contributions of dimer and hexamer formation to the
stability of aqueous insulin solutions were examined by varying the
equilibrium constants Kdim and Khex. These thermodynamic
parameters were based on values reported in the literature, and
were extrapolated to experimental conditions used in this study. The
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sensitivity analysis indicated how the uncertainty about the actual
magnitude of these parameters affected the pattern of aggregation.
Results of computer simulations using various values of the
dimerization constant are presented in Figure B.3. Changes of plus or
minus 10% in Kdim used in the proposed model had very little effect
on the kinetic profiles: the induction period remained virtually
unchanged, while the slope was only slightly affected, becoming less
steep when the dimerization constant was increased by 10%. These
0.6
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Figure B.3: Model sensitivity to changes in the equilibrium constant
of dimer formation (Kdim). Computer simulations were done using:
the model value (0), the model value +10% (A), and the model value
-10%(0).
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results indicated that the extent of dimerization directly affected
insulin stability, since this was the main route for decreasing
monomer concentration.
Results of computer simulations using various values of the
hexamerization constant are presented in Figure B.4. When this
thermodynamic parameter was increased or decreased by 50% of the
original value used in the model, the shape of the kinetic profile
remained unchanged, the duration of the induction period was not
affected, and only the slope of the curved portion varied slightly.
Smaller values of Khex resulted in a slightly steeper slope, since a
decreased concentration of hexamers coincided with increased
populations of dimers and monomers -- which were directly
involved in aggregate formation (step 6 in the reaction scheme,
Chapter 5). Similarly, larger values of Khex reduced monomer and
dimer concentrations, thereby slowing down the rate of aggregation.
However, these effects were very small, and changes in the kinetic
profile were hardly noticeable as long as Khex remained within the
specified order of magnitude range.
Simulations of Na- and Zn-insulin (Figure 5.2) indicated that
when Khex was changed by several orders of magnitude, both the
induction period and slope steepness were significantly affected.
This suggested that hexamerization played an important role in
increasing insulin solution stability, both by reducing dimer and
monomer concentrations, and by decreasing the number of
destabilizing (unoccupied) interfacial sites. Although the extent of
hexamer formation directly affected the rate of monomer
193
E0
0
U 0sr 0.3-
Q)od
o)
m ¢t
~040
~ 0 eA
a0
gJ0
0 12 24
Hours
Figure B.4: Model sensitivity to changes in the equilibrium constant
of hexamer formation(Khex). Computer simulations were done using:
the model value (0), the model value +50% (A), and the model value
-50%(0).
denaturation and subsequent aggregation, for the purpose of
predicting trends in insulin aggregation behavior, it was sufficient to
know Khex with ±50% accuracy.
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B.3 Model Sensitivity to Changes in the Equilibrium
Constant of Denaturation
The agitation dependence studies and experiments with
polypropylene (Chapter 4) pointed to the importance of Kdenat, which
contained information about mass transport to the solid-liquid
interface, shear effects, and destabilizing surface interactions. The
sensitivity analysis confirmed these conclusions; while variations in
K denat did not change the shape of the kinetic profile, both the
duration of the induction period and the steepness of the slope were
affected (Figure B.5).
When Kdenat was doubled, the total reaction time similarly
increased from 24 to 48 hours (the induction period became longer
and the slope less steep). A 50% reduction in the value of this
parameter led to a decreased induction period and a steeper slope,
while the total reaction time was shortened to 12 hours. These were
by far the most dramatic changes in the simulated kinetic profiles,
suggesting that monomer denaturation at the hydrophobic interface
was the rate limiting step in the aggregation reaction. This analysis
also identified this reaction step as the one most sensitive to
perturbations, and therefore the best candidate for stabilization
strategies. Stabilizing reagents aimed at reducing the value of Kdenat
(either by reducing mass transfer and shear effects, or by modifying
the nature of interfacial interactions) would have the most profound
effect on overall solution stability. Based on this sensitivity analysis,
nonionic surfactants (which prevented monomer denaturation by
occupying the destabilizing interfacial sites and minimizing the
number of unfavorable contacts between insulin and the
195
hydrophobic surface) were chosen to prevent insulin aggregation in
agitated aqueous solutions containing an air-water interface.
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Figure B.5: Model sensitivity to changes in the equilibrium constant
of denaturation (Kdenat). Computer simulations were done using: the
model value (0), 1/2 of the model value (A), and twice the value
used in the model (0).
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B.4 Model Sensitivity to Changes in the Size of
Intermediate Species
In the proposed kinetic scheme, it was assumed that once the
intermediate species reached the critical size U10, they had enough
surface area for stability and could interact with native monomers
and dimers (Chapter 5). Results of QELS analysis indicated that the
critical size was reached when some 100 unfolded monomers
combined to form a stable intermediate species (this rough estimate
of the intermedite's size is based on the 2 nm diameter of the insulin
monomer (Blundell et al, 1972)). However, because of the
uncertainty about the shape of the intermediate species and the low
resolution of light scattering measurements, the actual number of
steps required to reach the critical size could only be estimated. For
modelling purposes, the exact size of Un was not important, since the
characteristic shape of the kinetic profile could be simulated using a
any number (>1) of association steps to represent the delayed onset
of aggregation.
To illustrate this point, the number of association steps needed
to reach a critical size was varied from 4 to 14 (i.e., Un=U 5 and U1 5,
respectively). As can be seen from Figure B.6, these changes had
very little effect on the overall kinetic profile: the induction period
decreased by approximately one hour when U5 was used instead of
U10 to represent the critical size; likewise, when 14 association steps
were required to reach Un, the lag time increased by approximately
one hour. The slope of the curve remained unchanged during all
three simulations. This confirmed that the general shape of the
kinetic profile was independent of the number of association steps,
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Figure B.6: Model sensitivity to changes in the critical size of the
intermediate species. Computer simulations were done using U5 (0),
U10 (0) and U15 (A) to represent the critical size.
and that the assumption of a smaller critical size did not compromise
the model's ability to make qualitative predictions about insulin
aggregation.
However, better quantitative predictions could probably be
made if the size of the intermediate species used in the model was
closer to the size observed using QELS analysis. For example, a better
agreement between computer simulations and experimental results
of concentration dependence was obtained when the kinetic
198
OO R - - - -
parameters were determined based on 14 rather than 9 association
steps (Figure B.7). So while this simplifying assumption did not
hinder the model's ability to predict trends in insulin aggregation
behavior, quantitative modelling of the reaction scheme was limited
by the uncertainty about the size and shape of the intermediate
species.
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Figure B.7: Computer simulations of concentration dependence of
Zn-insulin aggregation (37 0 C, 80 rpm, 5 Teflon spheres) using U15 as
the critical size of the intermediate species.
simulations are represented by solid lines.
simulations using U10 as the critical size.
Results of computer
See Chapter 5 for
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B.5 Model Sensitivity to Insulin Adsorption at
Hydrophobic Surfaces.
The concentration dependence of insulin aggregation was
attributed to dimer and hexamer adsorption to and occupation of
hydrophobic interfacial sites. It was shown in Table 5.1 that in the
absence of adsorption, increased insulin concentrations would lead to
more rapid aggregation, since the driving force for monomer
denaturation would be elevated in proportion to the increase in
monomer concentrations. To further illustrate this point, the
concentration dependence of insulin aggregation was simulated
assuming no hexamer adsorption to Teflon (Figure B.8). The results
confirmed that in the absence of hexamer adsorption, higher insulin
concentrations would result in faster aggregation. If only hexamer
adsorption was eliminated from tle model, solution half-lives
increased proportionally with total protein concentrations (tl/2= 19,
18, and 16 hours for initial concentrations of 0.6, 0.4 and 0.2 mg/ml),
but mathematical simulations were in poor agreement with
experimental results, and underpredicted solution stability at higher
concentrations. The good agreement between the experimental
results and computer simulations at 0.2 mg/ml suggested that the
adsorption coefficient used in the model overpredicted insulin
adsorption at lower concentrations.
This analysis underscored the destabilizing effects of monomer
interactions with hydrophobic surfaces, and supported the
hypothesis that greater stability at higher concentrations was due to
dimer and hexamer interactions with interfacial sites. It also
indicated that dimer adsorption alone was not sufficient to explain
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increased solution stability, and that hexamer formation not only
reduced the number of unstable monomeric species, but also
contributed to excluding monomers from unfavorable interactions
with the hydrophobic surface.
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Figure B.8: Effects of hexamer adsorption to Teflon on the stability
of Zn-insulin solutions. Comparison of experimental results
(symbols) and computer simulations (solid lines) of the concentration
dependence of Zn-insulin aggregation assuming no hexamer
adsorption. See Figure 5.3 for simulation of Zn-insulin concentration
dependence in the presence of dimer and hexamer adsorption to
Teflon.
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